Public Health Considerations: Prevention of Infectious Diseases {#Sec1}
===============================================================

Infection Control and Prevention {#Sec2}
--------------------------------

### Childcare Centers {#Sec3}

Immunization: Required for all enrollees and staffAssist children with toileting and hand hygieneHand washing withsoap and water, alcohol-based antiseptic is acceptable if \> 24 months oldCareful food preparation and diaper changingDisinfecting environmental surfaces prevents diarrheal diseasesRespiratory etiquette (sneeze or cough into elbow)Exclusion and return policies:Use gloves when contacting body fluidsDo not exclude because oflice, ringworm, conjunctivitis without fever or behavior change, rash without fever**Common organisms in childcare centers** *Shigella* infectionTransmitted from infected feces (person-to-person contact)Do: Stool bacterialcultures for any symptomatic contactKnow: If *Shigella* infections are confirmed, administer appropriate antibacterial treatmentReturn to childcare center if diarrhea has resolved and stool culture is negativeNontyphoidal *Salmonella* speciesNo antibiotic is required except:Infants younger than 3 months of ageImmunocompromised hostInfected individuals should be excluded from childcare until symptoms resolve*Salmonella* serotype TyphiTreatment is indicated for infected individualsReturn to childcare center5 years of age or younger : 48 h after antibiotic treatmentOlder than 5 years: 24 h after the diarrhea has resolvedOther risk of infection: e.g., *Giardia*; rotavirus; cryptosporidiosis; respiratory syncytial virus (RSV); parainfluenza virus; adeno, rhino, and corona viruses; *Haemophilus influenzae*, *pneumococcal*, hepatitis A, and cytomegalovirus infections

### Hospital and Office {#Sec4}

Standard precautions are indicated in the care of all patients including:Hand hygiene before and after each patient contactProtective equipment when needed**Preventive methods** Alcohol-based products preferred because of their superior activity and adherenceSoap and water are preferred when hands are visibly soiled or exposed to a spore-forming organism ( is the most common), or for norovirusGloves, isolation gowns, masks, and goggles for any exposure to body fluids, contaminated materials, and sharpsStrict aseptic technique for all invasive procedures and for catheter careSeparate well and sick children areas in medical offices**Examples of infections and agents requiring transmission-based precautions** Contact precautions, e.g., RSV, *C. difficile*, other infectious diarrhea, and Gloves and gowns are required when there is direct patient contactDroplet precautions, e.g., influenza, , mumps, and Use of a surgical mask is requiredA single room is preferredRemember all office and hospital staff should receive an annual influenza immunizationAirborne precautions, e.g., , measles, varicella (with contact precautions), severe acute respiratory syndrome (SARS)Negative pressure airborne infection isolation roomRoom air needs 6--12 changes per hour or recirculation through a high-efficiency particulate air (HEPA) filterCertified N95 fine particle respirator mask or similar sealing mask

### Prevention of Infection Through Breastfeeding {#Sec5}

Exclusive breastfeeding for the first 4--6 months is recommended by American Academy of Pediatrics (AAP)Interrupt breastfeeding for:Breast abscessor cellulitis with direct contact with infant's mouth; can continue on other sideWomen with tuberculosis (for first 2 weeks of treatment, then acceptable)Maternal HIV (except in resource-limited settings)Maternal human T cell lymphotropic virus (HTLV) types 1 or 2Do not interrupt for maternal hepatitis B**Immunologic characteristics of breast milk** Postpartum colostrum contains highconcentrations of antibodies and other infection-protective elementsThe actual antibodies against specific microbial agents present in an individual woman's milk depends on her exposure and response to the particular agentsLactoferrin: Limitsbacterial growth by iron chelationLysozyme: Bacterial cell wall lysisLactalbumin: Enhances *Bifidobacterium* growth and modulates immune systemCasein: Limits adhesion of bacteria and facilitates the growth of *Bifidobacterium*Carbohydrates: Enhance the growth of probioticsLipids: Lytic effect on manyviruses and are active against *Giardia***Absolute contraindication of breastfeeding** Maternal HIV infection (except in resource-limited settings)HTLV1 and HTLV2Tuberculosis (active, untreated pulmonary tuberculosis, until effective maternal treatment for the initial 2 weeks or the infant is receiving isoniazid)Herpes simplex virus (HSV) infection on a breast (until the lesions are cleared)Breast abscess or cellulitis with direct contactwith infant's mouth; can continue on other side

### Prevention of Vector-Borne Disease {#Sec6}

Chemoprophylaxis before traveling to endemic areas, e.g., atovaquone/proguanil for malaria should be given before traveling to endemic areasUse mosquito netting (bed-net) during sleep in tropical areasUse protective clothingRepellents, e.g., DEET (\> 20%) applied to children should be used to prevent tick and mosquito bitesInsecticide should not be applied to children's hands because of risk of ingestionUse of occlusive clothing to prevent mosquito and tick bites is effectiveRemove tick from skin immediately, then wash with soap and waterKeep pets tick-freeImmunization against disease (e.g., yellow fever, typhoid, cholera, Japanese encephalitis, meningococcus, rabies if high risk) when traveling to endemic area at least 2 weeks before departure

### Recreational Water Use {#Sec7}

Exposure to contaminated water can cause diarrhea and other infections, e.g., swimmer's earis most common cause of recreational water-associatedoutbreaks; *Giardi*a is second, also *Shigella* is another causeRegularly test home pools for pH, free chlorine, or brominePeople with diarrhea should not participate in recreational water activitiesChildren with diarrhea should avoid swimming for 2 weeks after cessation of diarrhea (for *Cryptosporidium*)Avoid water ingestionClean the child with soap and water before swimmingChange diapers in the bathroom

### Antimicrobial Resistance {#Sec8}

Use of antimicrobials is the most important factor that leads to antimicrobial resistance, including inpatients and in agricultureDiseases for which antibiotics are not appropriate: Nonspecific cough, bronchitis, viral pharyngitis, common cold

### Infections in Immunocompromised Hosts {#Sec9}

**Malnutrition** Malnutritionincreases susceptibility to infections; repeat or chronic infections contribute to malnutrition. A vicious cycleMalnutrition increases severity of disease and risk of poor outcomesMalnutrition increases risk of bacterial versus viral diarrheaMalnutritionincreases risk of pneumonia**Central nervous system (CNS) diseases** Infants have immature hypothalamic thermoregulatory system and lack a central "control" of temperature, making their body temperature more susceptible to environmental temperatureInfants with CNS infection affecting thermoregulatory system may present with hypothermia**Asplenia** Example: Sickle cell anemia, congenital or surgical aspleniaIncreased risk for bacteremia and meningitis due to encapsulated organisms like *Streptococcus pneumoniae, H. influenzae* type b (Hib), and *N. meningitidis*Consider daily antimicrobial prophylaxis (especially for sickle cell disease)Special vaccine consideration for asplenia:Pneumococcal conjugate (PCV13) and polysaccharide (PPSV23) vaccines are indicatedFollowing PCV13 series, PPSV23 should be given at 24 months of age and 5 years laterMeningococcal conjugate vaccine (MCV) should be given at 2 months of age (MenACWY-CRM, e.g., Menveo). Revaccinate 3 years later and then every 5 years.(MenACWY-D, e.g., Menactra) cannot be given before 2 years of age**Malignancy** Fever and neutropenia (absolute neutrophil count \[ANC\] \< 500) increase the risk of bacterial infection. Investigate with blood and urine cultures, consider chest radiograph, and treat with antibiotic for Gram-positive and Gram-negative coverage (cefepime or piperacillin/tazobactam). Consider adding vancomycin if methicillin-resistant *S. aureus* (MRSA) colonized or if skin/soft tissue infection or sepsis present.Major infections in patients with cancer include: bacteremia due to intestinal translocation, invasive fungal infections including *Candida* and *Aspergillu*s, *Pneumocystis jiroveci* pneumonia.**Burn injury** Burn wounds aresusceptible to infection with Gram-positive and Gram-negativebacteria, yeast, and viruses (HSV, varicella-zoster virus \[VZV\])**Indwelling central lines** Central line-associated bloodstream infections (CLABSI) are a common complication. Obtain culture from central line**and** periphery, then begin vancomycin + cefepime or piperacillin/tazobactamIf MRSA or methicillin-sensitive *S. aureus* (MSSA), remove the line and continue treatment.

Viral Infections {#Sec10}
================

Cytomegalovirus (CMV) {#Sec11}
---------------------

**Background** CMV is adouble-stranded DNA virus and a member of the *Herpesviridae* familyAt least 60% of the US population has been exposed to CMVCMV usually causes an asymptomatic infection; afterward, it remains latent throughout life and may reactivate**Mode of transmission and period of communicability** Vertical transmissionCMV can bematernally transmitted: (1) transplacentally in utero, (2) at birth through infected maternal genital tract, and (3) postnatally by ingestion of CMV-positive human milk or transfusionRisk decreased by the use of pasteurized human milk or freezing human milkHorizontal transmissionExposure to CMV can occur from almost all body fluids, including:Urine, saliva, and tearsGenital secretions, blood transfusion, and transplanted organsToddlers infected postnatally with CMV shed the virus in their urine for a mean of 18 months (range 6--40 months)Healthy adults infected with CMV will shed the virus for up to several weeksShedding of CMV in toddlers inchildcare centers can be as high as 70%Transfusion and transplantationCan be eliminated by CMV-negative donorsFiltration to remove white blood cells (WBCs)Latent form in tissue and WBCs can be reactivated many years later**Congenital CMV infection** MicrocephalyPeriventricular calcifications (intracerebral)Chorioretinitis, strabismus, microphthalmia, and optic nerve atrophyHypotonia, poor feeding, ventriculomegaly, cerebellar hypoplasiaIntrauterine growth restrictionPrematurityJaundiceHepatosplenomegalyThrombocytopenia; petechiae and purpuraLater in childhood 7--15% will develop progressive sensorineural hearing lossDevelopmental delays**Diagnosis** Perinatally or postnatally:Confirmed bydetection of the virus in urine, blood, saliva or CSF by culture or polymerase chain reaction (PCR)Congenital CMV: If diagnosed in first 3 weeks of lifeImmunocompromised host:Test for pp65 antigen (CMV antigenemia assay) or quantitative DNA in blood or plasma**Treatment** Congenital CMVTreatment modestly improves hearing and neurodevelopmental outcomes for infantsCNS disease is treated with oral valganciclovir (or IV ganciclovir) for 6 monthsCMV retinitis in HIVGanciclovir and valganciclovir are indicated for induction and maintenance therapyCMV pneumonitis in bone marrow or stem cell transplant patientsGanciclovir plus CMV immune globulinare used together

Herpes Family Viruses (DNA Viruses) {#Sec12}
-----------------------------------

Epstein--Barr virus (EBV)HSV1, HSV2CMVVZVHuman herpesvirus type 6 (HHV-6), aka sixth diseaseHuman herpesvirus type 7 (HHV-7)HHV-6 and HHV-7 can both cause exanthema subitum, aka roseolaHuman herpesvirus type 8 (HHV-8, aka Kaposi sarcoma-associated herpesvirus)

Epstein--Barr Virus (EBV) {#Sec13}
-------------------------

**Background** EBV or human herpesvirus-4 is a gammaherpesvirus that infects more than 95% of the world's populationMode oftransmission primarily by oral contact with salivaEBV is shed in saliva at high concentrations for more than 6 months following acute infection and intermittently at lower concentrations for lifeYoung children directly or through handling toysAdolescents due to close contact such as kissing**Clinical presentation** EBV infection in healthy person; infectious mononucleosis (EBV is the most common cause)FeverExudative pharyngitis (similar to streptococcal pharyngitis but more painful)Cervical lymphadenopathy, commonly anterior, and posterior cervical lymph node (may compromise the airway)Splenomegaly (90%); 2--3 cm below the left costal margin is typicalHepatomegaly (10%)Fatigue and malaiseRashTypically a benign, self-limitedillness in healthy persons, but can cause fatal disseminated infection even in healthy hostsEBV infection in immunocompromised persons (transplant, HIV)Fatal disseminated infectionNonmalignant EBV-associated proliferations, e.g., virus-associated hemophagocytic syndromePost-transplant lymphoproliferative disordersX-linked lymphoproliferative syndromeNasopharyngeal carcinoma, Burkitt lymphoma, Hodgkin disease, non-Hodgkin lymphoma, gastric carcinoma**Diagnosis** Heterophile antibody test (monospot)Not recommended for children younger than 5 years of age as the result is not specific for acute mononucleosisHelpful for older children and adolescents with mono signs and symptomsEBV viral capsid antigen (VCA) immunoglobulin (Ig) M and IgG serology to distinguish acute from past infectionNo previous infection: Negative VCA IgG, negative VCA IgMAcute infection: Positive VCA IgG, positive VCA IgMRecent infection: Positive VCA IgG, +/− VCA IgM, positive early antigenPast infection: Positive IgG, negative VCA IgM, negative early antigen, positive nuclear antigen**Management** Ampicillin or amoxicillin may cause morbilliform rashDecrease immunosuppressive therapy in transplant patients if possibleShort courses of corticosteroids for fewer than 2 weeks can be given in the following cases:Tonsillar inflammation with impending upper airway obstructionMassive splenomegalyMyocarditisHemolytic anemiaHemophagocytic lymphohistiocytosis (HLH)**Complications** Splenomegaly:Avoid strenuousactivity and contact sports for 21 days after onset, then limited noncontact aerobic activity if no overt splenomegalyContact sports allowed 4--6 weeks after onset if no splenomegalyFatigue may persist for 3--6 months or longer

Herpes Simplex Virus 1 and 2 (HSV1 and HSV2) {#Sec14}
--------------------------------------------

Characterized by neurovirulence, latency, and reactivation in the area supplied by the ganglia in which latency was establishedReactivation induced by various stimuli (e.g., fever, trauma, emotional stress, sunlight, and menstruation)Spread by direct contact with lesions or infective secretions**Epidemiology** Neonatal:Exposure during passage through birth canal or ascending infection through ruptured or apparently intact membranesRisk greatest with maternal primary infection near time of delivery (25--60%) versus 2% risk if recurrent maternal infectionMost neonatal HSV cases born to mothers with no HSV symptomsChildren and adolescents:Shed virus for \> 1 week with primary genital infection (high viral concentration)Shed virus for 3--4 days with recurrent infectionReactivation without symptoms is commonIncubation period is 2 days--2 weeks**Clinical manifestations** Neonatal (3 forms that may overlap):25%: Disseminated disease affecting mostly liver, lungs, and CNS; "sepsis" clinical picture30%: CNS disease "meningoencephalitis"45%: Skin, eye, and mouth (SEM) diseaseChildren and adolescents:Most primary HSV is asymptomatic; reactivation is also mostly asymptomaticGingivostomatitis is the most common clinical manifestation; usually HSV1, associated with fever, irritability, submandibular lymphadenopathy and ulcerative gums and buccal mucosa. May recur as "fever blister" or "cold sore"Genital herpes: Genital vesicles or ulcers of genitalia and/or perineum, HSV1 or HSV2. Immunocompromised may have more recurrenceEczema herpeticum occurs when patients with atopic dermatitis are infected with HSV, having ulcerative and/or vesicular areas on top of eczematous lesionsEncephalitis results from primary or recurrent HSV, with fever, altered mental status, seizures. Magnetic resonance imaging (MRI) may show temporal lobe abnormalities. CSF may show increased red blood cells, but not if early in disease courseAseptic meningitis is usually mild and associated with HSV2

Herpetic Whitlow (Fig. [9.1](#Fig1){ref-type="fig"}) {#Sec15}
----------------------------------------------------

Due toautoinoculation of HSVVesiculoulcerative lesions affect the pulp of the distal phalanxof the finger associated with deep-seated swelling and erythemaOral antiviral medications areoptional and are used in extensive disease Fig. 9.1Herpetic whitlow:Herpetic Whitlow infection in a 2-year-old with vesicularlesions, ulcer, and surrounding erythema involving the base of the thumb

Herpes Gladiatorum (Fig. [9.2](#Fig2){ref-type="fig"}) {#Sec16}
------------------------------------------------------

Herpes gladiatorum occurs in contact sports, e.g., wrestling and boxingMost commonly affects exposed areas, e.g., face and upper extremitiesPatients should avoid contact sports during outbreaks until the culture or PCR results are negativeSuppressive therapy is likely to beeffective, but data about such therapy are insufficient**Treatment** Antivirals: Acyclovir, valacyclovir, famciclovirNeonatal: IV acyclovir for 14 days (SEM disease) or 21 days (disseminated disease or CNS disease); begin therapy before test results returnAll infants withany type of HSV should have ophthalmologic assessmentRepeat lumbar puncture near end of therapy for HSV CNS disease and continue treatment if positiveOral acyclovir suppressive therapy indicated for 6 monthsGenital, primary: Oral acyclovir for 7--10 daysGenital, recurrent: Same as primary; can be used routinely or at start of an episodeMucocutaneous, immunocompromised: IV acyclovirMucocutaneous, healthy host: May benefit from therapy, oral acyclovir for 5--7 daysCNS encephalitis: IV acyclovir for 21 days Fig. 9.2Herpes gladiatorum:16-year-old boy wrestling player presents withpainful blisters in the left ear

Varicella-Zoster Virus (VZV): Chickenpox and Shingles {#Sec17}
-----------------------------------------------------

**Background and epidemiology** VZV is herpesvirus family memberIncubation period is 2 weeksContagious 1--2  days before rash until all lesions are crusted overSpreading via airborne or direct contact with mucosa of upper respiratory tract or conjunctiva, and transplacental passageVZV is the cause of varicella (chickenpox) and herpes zoster (shingles)Varicella is more contagious than zosterImmunity to varicella is lifelong; reactivation as zoster infection is possibleImmunocompromised athigher risk for severedisease and disseminated infection**Clinical presentationVaricella (Chickenpox)** The prodrome: low-grade fevers,headaches, and malaiseSkin lesionsinitially appear on the face and trunkLesions start as red macules and pass through stages of papules, vesicles with central umbilication, pustules, and then crust overThe vesicle on the erythematous base of a lesion leads to its description as a "pearl" or "dewdrop on a rose petal"Lesions predominate in central skin areas and proximal upper extremities with relative sparing of distal and lower extremitiesChickenpox generally is a benign self-limited illness, and is more severe in adults, adolescents, and infants compared to older childrenComplications include bacterial superinfection, especially with , which can progress to cellulitis, myositis, and sepsisPneumonia (major cause of morbidity and mortality), hepatitis, and thrombocytopenia are also possibleImmunocompromised patients mayexperience visceral dissemination, encephalitis, hepatitisNeonates whose mothersdevelop varicella 5 days to 2 weeks before delivery have increased risk of death dueto diminishedmaternal antibodies**Herpes zoster (shingles)** Latency establishes in sensory ganglia infected duringprimary VZV or vaccinationShingles classically is a unilateral rash consisting of grouped vesicles on an erythematous base, covering 1--3 adjacent dermatomes, often accompanied by pain and pruritus (Fig. [9.3](#Fig3){ref-type="fig"})Postherpetic neuralgia, painafter rash resolves, is uncommon in pediatrics**Treatment of VZV** Healthy host: Keep fingernails short, topical calamine for itching, acetaminophen for fever, avoid salicylates due to risk of Reye's syndromeImmunocompromised host: IV acyclovir within 24 h of rash onsetUnvaccinated \> 12 years old, chronic skin or lung disorders: Acyclovir or valacyclovir**Prevention in immunocompromised exposure** VariZIG (varicella-zoster immune globulin) or IVIG within 4 days (ideal) and up to 10 days post-exposure. Isolate for 28 days after exposureAlternative is oral acyclovir or valacyclovir starting 7 days after exposure. Isolate for 21 days after exposure**General prevention** Children can return to school if all lesions are crustedAirborne isolation for hospitalizedpatients with varicellaCover skin lesions for patients with herpes zosterImmunize all persons who lack evidence of immunityImmunize exposed, unvaccinated persons from 3 to 5 days post-exposureDischarge or isolate exposed patients without evidence of immunityVariZIG given to the baby born to mother who develops illness from 5 days before until 2 days after birthIV acyclovir is indicated for varicella infection in infants born to mothers who experience chickenpox from 5 days before until 2 days after delivery Fig. 9.3(**a**) 2-year-old girl with painfulherpes zoster rash (shingles). (**b**) 4-year-old boy with herpes zoster (shingles)

Human Herpesvirus Type 6 (HHV-6) {#Sec18}
--------------------------------

### Including Roseola Infantum (Exanthem Subitum) {#Sec19}

**Background** Commonly affects children ages 6--18 months old**Clinical presentation** (Fig. [9.4](#Fig4){ref-type="fig"})Typically, anonspecific febrile illness without rashVery high fever for 3--7 days, followed by maculopapular rash in 20% after fever resolves; rash can last hours to daysThey may have lymphadenopathy, vomiting, diarrhea, febrile seizure, or respiratory symptoms10 to 15% of children with primary HHV-6 will have febrile seizuresPrimary infection establishes latency that may reactivate (all herpes viruses)Immunocompromised may develop bone marrow suppression, graft rejection, pneumonia, encephalitis, hepatitisIncubation is 9--10 days**Management** Mainly supportive for healthy hostFor immunocompromised, may consider ganciclovir, valganciclovir, or foscarnet**Human herpesvirus-7 (HHV-7)** Childhood febrile illness,also causes exanthem subitum (roseola)Most infections areasymptomaticLike HHV-6, establishes latency that may reactivate85% of healthy adultshave evidence of past infection**Human herpesvirus-8 (HHV-8)** Kaposi sarcomaA trigger for hemophagocytic lymphohistiocytosis (HLH)Multicentric Castleman disease Fig. 9.4Roseola infantum: 9-month-old boy afebrile presents with small, pale pink papules and blanchable, maculopapular exanthem, had high fever for 3 days before the rash

### Other DNA Viruses {#Sec20}

Parvovirus B19Adenovirus

Parvovirus B19 {#Sec21}
--------------

### *Erythema Infectiosum*/Fifth Disease {#Sec22}

**Background** Incubation period 4--14  daysMode of transmission: Respiratory secretions**Clinical presentation** Mild constitutional symptoms, e.g., fever, malaise, myalgia, and headacheBright red facial rash (slapped cheek appearance \[Fig. [9.5](#Fig5){ref-type="fig"}\])Circumoral pallorLacy maculopapular rash lasting for 2--4 days begins on the trunk and moves to extremities (Fig. [9.5](#Fig5){ref-type="fig"})Rash may be pruritic, does not desquamate, and may recur with bathing or exerciseArthritis or arthralgia may occurMild respiratory illness without rashPurpuric rash in a gloves and socks distributionPolyarthropathy syndrome (mostly adults)Chronic erythroid hypoplasia and severe anemia (HIV, immunodeficient)Aplastic crisis for 7--10 daysOccurs in persons with hemolytic disease such as sickle cell anemia, spherocytosis, and thalassemiaTransient low to zero reticulocytes, leukopeniaHepatitis and myocarditis (rare)Hydrops fetalis2 to 6% risk of fetal death if occurs during pregnancy; increased risk earlier in pregnancyCan be asymptomatic or subclinical**Remember** Rash is not infectious, and children can go to school without restrictions Fig. 9.5(**a**) *Erythema infectiosum*: Erythematousmaculopapular rash on the arm, which fades into a classic lacelike reticular pattern as confluent areas clear. (**b**) Classic slapped-cheek appearance of fifth disease

Adenovirus {#Sec23}
----------

**Background** Mode of transmission:Person to person through contact with conjunctival and respiratory secretionsFecal--oral transmission and via fomitesOutbreaks usually are concentrated in winter, spring, and early summer; otherwise all year roundPersist in environment and resist disinfectantsIncubation period:Respiratory infections from 2 to 14 daysGI diseasefrom 3 to 10 days**Clinical presentation** Upper respiratory tract infection:Nonspecific febrile illnessOtitis mediaPharyngitisExudative tonsillitisPneumoniaFollicular conjunctivitis (clinically similar to enterovirus conjunctivitis)GastroenteritisHemorrhagic cystitisPharyngoconjunctival fever:Fever, tonsillitis (sometimes suppurative)Follicular conjunctivitis, coryza, and diarrheaCervical and preauricular lymphadenopathy is commonGeneralized rash in association with fever, conjunctivitis,and pharyngitiscan be mistaken for Kawasaki disease**Laboratory** PCR (preferred), antigen detection, and viral culturePersistent and intermittent shedding complicates diagnostics**Management** Supportive treatment in healthy hostConsider cidofovir inimmunocompromised with severe disease

Respiratory viruses {#Sec2400}
-------------------

InfluenzaParainfluenzaRespiratory syncytial virusHuman metapneumovirusRhinovirusCoronavirus

Influenza Virus {#Sec24}
---------------

**Background and epidemiology** Influenza is an orthomyxovirusTypes: A, B, and C. Types A and B are responsible for epidemic disease in humansInfluenza A viruses found in humans are H1N1 and H3N2Some strains are more virulent, causing more severe disease than othersFrequent antigenic change, or antigenic drift:Point mutations causing minor antigen changes, leads to new influenza virus strains that cause seasonal epidemics in winterReason for constant reformulation of influenza vaccine to include new virus strainsOccasional antigenic shift:Mutations causing major antigen changes, leads to new influenza virus subtypes that contain a new hemagglutinin (HA) or neuraminidase (NA), causing pandemicsMost recent pandemic: 2009--2010 caused by influenza A (H1N1)Mode of transmissionLarge-particle respiratory droplet between individuals (cough, sneeze)Contact with contaminated surfaces; fingers then touch faceIncubation period is 1--4 daysMost outbreaks occur in schoolsHospitalization rates are highest in children \< 2 years and elderly \> 65 years**Clinical presentation** Fever, malaise, myalgia, headache, nonproductive cough, sore throat, and rhinitisChildren may also develop croup or bronchiolitisYounger children may have febrile seizures or sepsis-like symptomsUncomplicated influenza diseasetypically resolves within 3--7 days**Complications** Primary viral pneumoniaSecondary bacterial infections such as pneumonia (*S. aureus* and *S. pneumoniae*)Sinusitis and otitismediaEncephalitisUnderlying medical conditions such as asthma, diabetes, sickle cell, immunosuppression, neurologic disorders, or congenital heartdisease increase risk for complications, including hospitalization**Diagnosis** Reverse transcription-PCR and multiplex PCR (testing for multiple respiratory viruses at once)Rapid antigen-detection tests, immunofluorescenceNasopharyngeal (NP) swab specimens have highest yieldFor hospitalized patients with lower respiratory tract disease, obtain endotracheal or bronchoalveolar lavage (BAL) specimeneven if NP negative**AAP immunization guidelines** Annual vaccination of all children ages 6 months through 18 years before the start of influenzaseasonRegardless ofseasonal epidemiology, children 6 months through 8 years of age who previously have not been immunized against influenza require two doses of trivalent or quadrivalent inactivated influenza vaccine or live-attenuated influenza vaccine (LAIV) administered at least 4 weeks apart to produce a satisfactory antibody responseChildren \> 9 years and those who have received two doses in a previous year receive a single dose annuallySpecial emphasis for those with underlying medical conditions, including asthma, hemodynamically significant cardiac disease, HIV, persons on aspirin therapy, sickle cell, diabetes, renal disease, pregnancyEgg allergy is not a contraindication to influenza vaccine! (but was in the past....)**Treatment** Prophylaxis withoseltamivir or zanamivir can be given at the same time as immunization and should be considered for immunosuppressed, unimmunized, close contacts of persons at high risk for complications, and for all when seasonal vaccine does not match circulating strainsChildren who have influenza and are at high risk for complications, regardless of the severity of their illnessHealthy children who have moderate-to-severe illnessThree antivirals used in pediatrics:Oseltamivir is administered orally, approved for \> 2 weeks old; most common adverse effects are nausea and vomiting, although neuropsychiatric events have been reportedZanamivir is inhaled, approved for treatment (age \> 7) and prophylaxis (age \> 5)Baloxavir in children ≥ 12 years administered as a single oral doseAdamantanes (amantadine and rimantadine) no longer recommended due toresistance

Avian Influenza H5N1 {#Sec25}
--------------------

**Background** Reported cases were in south Asia, Iraq, Turkey,and EgyptHighly pathogenic strain in birds and poultryNot a humanstrain**Mode of transmission** Humans who have close contact with infected birds or poultryVisiting market selling live infected birds**Clinical presentation** Severe lower respiratory diseasein infected persons**Prevention** H5N1-specific vaccine (developed and approved)Avoid visitingmarkets where live birdsare soldThorough cooking inactivates the virus, but avoidance of poultry if there a concern is more appropriate

Parainfluenza Virus (PV) {#Sec26}
------------------------

**Background and epidemiology** Parainfluenza virusesare paramyxoviruses distinctfrom the influenza familyPrevious infection does not confer immunity, so reinfection can occurTransmitted via contact with NP secretions and respiratory droplets and fomitesSeasonal patterns of transmission: PV1 and PV2 occur in fall, PV3 occurs in spring, and PV4 occurs year-roundChildren shed virus for 1 week before symptoms and for 1--3 weeks after symptoms resolveIncubation period is2--6 days**Clinical manifestation** May causeclinical syndrome similarto influenzaMajor cause of laryngotracheobronchitis (croup) in children (see "Respiratory" section)Can also cause pneumonia, bronchiolitis, and otitis mediaMost parainfluenza infections are self-limited, but immunocompromised can have severe pneumonia anddisseminated disease**Treatment** Supportive care, as most infection is self-limitedCorticosteroids lessen severity, complications, and need for hospitalizationNebulized racemic epinephrine for severe croup with significant inspiratory/expiratory stridor and retractions

Respiratory Syncytial Virus (RSV) {#Sec27}
---------------------------------

Infection with RSV, the most common cause of bronchiolitis (See Chap. 10.1007/978-3-030-21267-4_20 "Pulmonology")**Prevention** Palivizumab: Humanized monoclonal immunoglobulin, recombinant DNA technologyReduces risk of lower tract disease in high-risk childrenAdministered every 30 days during RSV season (max 5 doses/season)Considered for first 1--2 years of lifeIndicated for:Preterm infants with chronic lung diseaseInfants with hemodynamically significant congenital heart diseasePreterm infants \< 29 weeks gestational ageAnatomic pulmonary abnormalities or neuromuscular disorderProfoundly immunocompromised children

Human Metapneumovirus {#Sec28}
---------------------

**Background and epidemiology** Humans are the only sourceSpread via contact with infected secretionsA leading cause of bronchiolitis in infantsOverlap withRSV season (winter--spring)**Clinical presentation** Bronchiolitis indistinguishable from RSV bronchiolitisCan also causepneumonia, croup, upper respiratory infectionSecondary bacterial infection with *S. pneumoniae* can occurSevere disease in immunosuppressed and history of preterm deliveryMost children have one human metapneumovirus infection before 5 years of age**Treatment** Supportive

Rhinoviruses {#Sec29}
------------

**Background and epidemiology** The mostcommon cause of commoncold (25--80% of cases)The common cold is an acute respiratory tract infection characterized by mild coryzal symptoms, rhinorrhea, nasal obstruction, and sneezingThe most common viral trigger for asthma exacerbationAbout 200 antigenically distinct viruses from 8 different genera can cause common cold (66--75%)Children typically have 2 episodes/year; adults have 1 episode/year**Clinical features** Pharyngitis, nasal congestion, and dischargethat goes from clear to mucopurulentMalaise, headache, myalgia, cough, feverSymptoms peak at 3--4 days and last 7 daysCan cause otitis media,bronchiolitis, andpneumonia**Testing** Not useful clinicallyPCR preferred,usually paired with enterovirus PCR due to genetically conserved regions

### GI Viral Infection {#Sec30}

Norovirus (Norwalk virus) and SapovirusRotavirus

Norovirus and Sapovirus {#Sec31}
-----------------------

**Background and epidemiology** Norovirus, formerly referred to as Norwalk virus, is the most common cause of epidemic nonbacterial gastroenteritis in the worldNorovirus is the leading cause of viral gastroenteritis cases in the USA, after rotavirus vaccine introductionNorovirus causes death in young children and the elderlySapoviruses also cause outbreaksOutbreaks of both occur incrowded areas (schools, long-term care facilities, cruise ships)Transmission is fecal--oral or vomitus--oral, contaminated food/water, contaminated surfaces, airborne transmission of vomitus documentedHighly resistant to environmental decontamination, including alcohol hand cleansersIncubation period is 12--48 hShedding may last 4 weeks in healthyhost, and \> 6 months in immunocompromised**Clinical presentation** Abrupt onset of nausea and vomiting (profuse, nonbloody, nonbilious) more common in adultsWatery diarrhea (non-bloody) may be the only symptom in childrenAbdominal crampsHeadachesLow-grade fever is commonMyalgias and malaiseChronic gastroenteritis in immunocompromisedSymptoms last 24--48 h, longer in children, immunocompromised, and elderly

Rotavirus {#Sec32}
---------

**Background and epidemiology** Causes severe acute gastroenteritisShed in stool days before and after clinical illnessTransmitted fecal--oral, possibly respiratoryLate winter to early spring transmissionStable in environment for weeks to monthsRotavirus was most common viral cause of acute gastroenteritis until vaccine introduction that reducedhospitalizations by 75% for children \< 5 years**Clinical presentation** Acute onset vomiting, then 24 h later severe watery diarrheaUp to 33% have high feverFirst infection is more severeCauses dehydration, electrolyte imbalance, and metabolic acidosisSymptoms last 3--7 daysImmunocompromised may have severe, prolonged, and fatal symptoms**Diagnosis** Antigen assay testing(enzyme immunoassay,chromatographic immunoassay, latex agglutination)

### RNA Viruses {#Sec33}

EnterovirusHIVMeaslesMumpsRubellaRabiesArboviruses

Enteroviruses (Non-polio Viruses and Poliomyelitis) {#Sec34}
---------------------------------------------------

### Non-polio Viruses (Echovirus, Coxsackievirus, and Numbered Enteroviruses) {#Sec35}

**Background and epidemiology** More common in the summer and fallHumans are the only known reservoir for humanenterovirusesEnteroviruses transmitted by the fecal--oral route and respiratory routeSurvive in environment for long periodsOutbreaks can occurMost severe disease in infants and young childrenViral shedding in stool(weeks to months) and respiratory secretions(1--3 weeks)**Clinical manifestations** Meningitis/encephalitisEnterovirus isthe most common cause of meningitis in pediatrics (bacterial or viral)Meningitis commonly caused by echovirusCommon in older childrenFever, headache, photophobia, and nuchal rigidity, CSF pleocytosisSevere complications: Seizure, hemiparesis, hearing loss, and mental deteriorationNo signs of toxicity (hypotension, hypoperfusion) as in bacterial meningitisBest diagnostic test:CSF enterovirus PCRHerpanginaCaused by many enteroviruses, including coxsackievirus type ASudden onset ofhigh fever in children 3--10 years of age, and can be associated with vomiting, malaise, myalgia, and backachePoor intake, drooling, sore throat, dysphagia, and dehydration may occurOral lesions:One or more small tender papular pinpoint vesicular lesions, on erythematous base on anterior pillars of the fauces,soft palate, uvula, tonsils, and tongue, then ulcerate in 3--4 daysHand, foot, and mouth disease (Fig. [9.6](#Fig6){ref-type="fig"})Mostly caused bycoxsackie A16 andenterovirus 71Fever (may be present)Oral vesicles and ulcers on buccal mucosa and tonguePainful erythematous vesicles on hands and feet; it may affect the groin and buttocksUsually last for 7--10 daysMost common complication is dehydration due to odynophagiaAcute hemorrhagic conjunctivitis (similar to adenovirus conjunctivitis)Subconjunctival hemorrhageSwelling, redness, and tearing of the eyeResolves spontaneously within 7 daysMyocarditis/pericarditisCommonly caused by coxsackievirus B or echovirusCommon symptoms: Shortness of breath, chest pain, fever, and weaknessCongenital and neonatal infectionSepsis-like syndromeassociated with maternal enterovirus infection and lack of maternal immunityCan range frommild febrile infection to encephalitis and negative bacterial cultureCan cause hepatic necrosis**Diagnosis** PCR fromrectal swab, stool, throat, nasopharynx, conjunctiva, trachea, blood, urine, tissue biopsy, and CSFMost respiratory panels with multiplex PCR do not distinguish enterovirus from rhinovirus due to genetic similarity and testing for a shared, conserved region in genomeEnterovirus 71 often has negative PCR testing**Treatment** Supportive , and IVIG can be considered for immunocompromisedto reduce illness and duration of shedding Fig. 9.6Hand, foot, and mouth disease. (**a**) Tender maculesin the hand. (**b**) Tendermacules and vesicles in both feet. (**c**) Multiple painful vesicles on the hard palate. (**d**) Erythematous macules all over the body and feet in an 18-month-old who has fever and oral ulcers

Poliomyelitis {#Sec36}
-------------

**Background and epidemiology** Humans arethe only reservoirsThree serotypes: Types 1, 2, and 3; type 2 eradicated globally; type 3 not seen since 2012; only type 1 is currently circulatingParalytic disease caused by wild type or live, oral vaccine virusStable in liquid environment (pools, ponds, etc.)After illness, virus persists in throat (1--2 weeks) and GI tract (3--6 weeks)Incubation period 3--6 days; paralysis occurs 1--3 weeks after exposure**Clinical presentation** Asymptomatic infection in 70%Fever and sore throat in 25%Aseptic meningitis in 1--5%Flaccid paralysis in a descending manner without reflexes in \< 1%Follows febrile illnessSymmetric paralysis affecting proximal musclesCranial nerve and diaphragm/intercostal muscle involvement may affect respiration33% recoverAffects anterior horncells in the spinal cord**Diagnosis** Cell culture of pharynx,stool, and CSF obtained as early as possible**Treatment** Supportive

Human Immunodeficiency Virus (HIV) {#Sec37}
----------------------------------

**Background** HIV is RNA virusHighest infectivity due to the very high (3--4 weeks) initial viremiaNearly all patientsseroconvert within 6 months of acquiring the infection**Mode of transmission** Transmitted by two principal modes in the pediatric age group:Mother-to-childTransplacental transferExposure to maternal blood, amniotic fluid, and cervicovaginal secretions during deliveryPostpartum through breastfeedingBehavioral (risk behavior in adolescent either unprotected sex or injection drugs)Other transmission modes include needlestick injury, mucous membrane exposure, and transfusion**Clinical presentation** During the "window" period:Infected person has a negative HIV antibody test result, but HIV RNA testing results are usually positiveAcute retroviral syndrome, characterized by:Fever, lymphadenopathy, rash, myalgia, arthralgia, headache, diarrhea, oral ulcers, leukopenia, thrombocytopenia, and transaminitisRed flags for HIV infectionThrush in apparently healthy child or adolescentInvasive candidal infectionsRecurrent severe infectionsLymphadenopathy and/or hepatosplenomegalyFailure to thriveParotid enlargementOpportunistic infections*Pneumocystis jiroveci* pneumonia*Mycobacterium avium* complexCytomegalovirus*Toxoplasma gondii*Human viscerotropic leishmaniasis**Diagnosis: Perinatal and postnatal infection** Preferred overall test in infants and children \< 18 months is HIV DNA PCR; highly specificby 2 weeks of age55% sensitivity at birth that increases to 100% by age 3 monthsPreferred test for HIV-1 infection is HIV RNA PCR because of greater clinical experienceSome use both to obtain viral load and confirmationMaternal antibody transfer can complicate diagnosticsIn HIV exposed, test at delivery, 2--3 weeks, 1--2 months, and 4--6 monthsPresumed negative in children \< 18 months if: Two negative HIV DNA or RNA tests from separate specimens at \> 2 weeks of age, one negative HIV DNA or RNA test from \> 8 weeks of age, or one negative HIV antibody test at \> 6 months of age and no clinical or laboratory evidence of infectionDefinitive negative in non-breastfed \< 12 months: At least 2 negative HIV DNA or RNA virologic tests from separate specimens at \> 1 month and \> 4 months, at least 2 negative HIV antibody tests from separate specimens at \> 6 months and no clinical or laboratory evidence of infection**Diagnosis: Adult and adolescent infection** Conduct initial serology, followed by confirmatory serology testingFor initial serology testing:Antibodies to HIV-1/HIV-2 and HIV-1 p24 antigen (fourth generation)Antibodies to either HIV-1 and HIV-2 (third generation)For confirmatory serology testing:Differential antibody testing to HIV-1 and HIV-2HIV-1 Westernblot and HIV-1 indirect immunofluorescence assay**Evaluation of HIV positive children** CD4 percentage and absolute cell countsPlasma HIV RNA concentration (viral load)HIV genotype to assess for baseline resistance and mutationsComplete blood count with differential countSerum chemistries with liver and renal function testsLipid profile and urinalysisFor children younger than 5 years of age, CD4 percentage is the preferred test for monitoring immune statusScreening for hepatitis B, hepatitis C, and tuberculosis is recommended for all HIV positive patients**Treatment of HIV** Triple-drug combination antiretroviral therapy effectively controls HIV infection**Prevention** Breastfeeding iscontraindicated in HIV positive mothersAll exposed infants should receive 6 weeks of zidovudineCondoms and abstinence are the best forms of preventing sexual transmission of AIDSCesarean delivery and treatment of HIV-positive mothers (especially with high viral load) decreases the risk of transmission of HIV to their infantsImmunization of infants and childrenImmunization schedule for HIV-exposed children is the same as for their healthy peers, with only a few exceptions:Patients who have severely symptomatic illnessPatient with CD4 percentage of less than 15% or CD4 counts of less than 200 cells/mm^3^ should not receive MMR, varicella vaccines, or other live vaccinesAnnual influenza immunization is recommended for all children older than age 6 months, but only the killed vaccine

Measles Virus {#Sec38}
-------------

**Background** Mode of transmission: Respiratory droplets (airborne)Infectious for 3--4 days before the onset of morbilliform rash and 4 days after the exanthem**Diagnosis** PCR testing, IgM detection, 4-fold rise in IgG serology, cell cultureIgM detection is preferred test**Clinical presentation** High feverplus coryza, cough, conjunctivitisRash develops next: Erythematous, morbilliform, maculopapular rash spread from face downward and disappears the same wayKoplik spots (white spots on oral mucosa) during prodromeComplications in young children and immunocompromised include otitis media, bronchopneumonia, croup, diarrhea, and deathDeath is also more common with severe malnutritionSevere complication:Acute encephalitis with permanent brain damage**Control and prevention** Vaccinate non-immunes within 72 h of exposureImmune globulin within 6 days of exposure for non-immunes if vaccination not possible, including pregnant women, severe primary immunodeficiency, bone marrow or solid organ transplant recipient, acute lymphoblastic leukemia, HIV AIDS with severe immunosuppression, and infants whose mothers received immunomodulatory drugs during pregnancyHIV on antiretroviral therapy and documented measles vaccination × 2: Treat as immuneVaccinate all health-care personnel

Mumps {#Sec39}
-----

**Background** An acute, self-limited, systemic viral illness characterized by the swelling of one or more of the salivary glands, typically the parotid glands**Mode of transmission** Contact to respiratory secretionsIncubation period is 16--18 days**Clinical presentation** Symptoms in the patient's history consist mostly of fever, headache, and malaiseWithin 24 h, patients may report ear pain localized near the lobe of the ear and aggravated by a chewing movement of the jawUnilateral or bilateral parotid swelling (Fig. [9.7](#Fig7){ref-type="fig"})Orchitis may occur after puberty; rarely causes sterility**Complications** Rare: Arthritis,thyroiditis, glomerulonephritis, myocarditis, transverse myelitis, encephalitis, oophoritis, permanent hearing impairment**Diagnosis** (Table [9.1](#Tab1){ref-type="table"})PCR from buccal swabs, throat washings, saliva, or CSFViral cell cultureSerology**Treatment** Supportive care onlySchool exclusion for 5 days from onset of parotid gland swellingUnimmunized children should stay out of school for 26 days after onset of parotitis in the last person with mumps in the affected school. Fig. 9.7Child with unilateral parotitis Table 9.1Differences between viral and bacterial parotitisViral parotitis (mumps)Bacterial parotitisWell-appearingToxic-appearing or ill-lookingNo fever or low-grade feverHigh feverMild tendernessModerate or severe tendernessNormal labs, positive mumps IgMLeukocytosis, shift to the left, high CRP*IgM* Immunoglobulin M, *CRP* C-reactive protein

Rubella Virus {#Sec40}
-------------

**Epidemiology** Transmitted via direct or droplet contact with respiratory secretionsPeak incidencefrom winter to spring25 to 50% asymptomaticLifelong immunityCan transmit 3 days before to 7 days after rash appearsInfants with congenital rubella may shed for 1 year in nasopharyngeal secretions and urineThe USA has not experienced rubella transmission since 2004; imported cases occurThe Americas have not experiencedrubella transmission since 2009Incubation period: 16--18 days**Clinical presentation** Congenital rubella syndromeConstellation of congenital anomaliesOphthalmologic (cataracts, microphthalmos, congenital glaucoma)Cardiac (patent ductus arteriosus, peripheral pulmonary artery stenosis)Auditory (hearing impairment)Neurologic (meningoencephalitis, microcephaly, mental retardation, autism)Neonates will have growth restriction, interstitial pneumonitis, hepatosplenomegaly, thrombocytopenia, and dermal erythropoiesis that manifests as "blueberry muffin" rashNeonates may also have metaphyseal lucencies (also seen in vitamin D intoxication/hypercalcemia, rickets, scurvy, arsenic and heavy metal poisoning, leukemia, congenitalsyphilis, sicklecell disease, congenital hypothyroidism)Increased risk of congenital defects if fetal infection occurs early in pregnancyPostnatal rubellaSubclinical or mild diseaseErythematous maculopapular rashForchheimer spots: Rose-colored spot on soft palateLymphadenopathy (posterior auricular or suboccipital nodes)ConjunctivitisAdolescent females susceptible to transient arthralgia and arthritisRare complications:Encephalitis, thrombocytopeniaInfants with congenital rubella may shed the virus from the nasal mucosa \> 1 year to susceptible contact

Rabies Virus {#Sec41}
------------

**Background** RNAvirus classified in the *Rhabdoviridae* familyUsually transmitted by bats and carnivores, e.g., raccoons, foxes, and coyotesAlmost never transmitted by squirrels, chipmunks, rats, mice, rabbits, and guinea pigs**Clinical presentation** AnxietyDysphagiaSeizuresEncephalitisIn most cases, progress to death**Treatment** Prompt local flushing and cleaning the wound with soap and waterPassive and active immunization for:All persons bitten by bats, carnivores, e.g., raccoon, foxes, and coyotesOpen wound or scratch contaminated with saliva of infected animals or humanNo prophylaxis if domestic dog, cat or ferret that can be observed for 10 daysDomestic animals that may be infected should be euthanized and testedThe need for tetanusand local wound care should be considered**Passive and active immunization should be started as soon as possible** Human rabies immunoglobulin (passive)Rabies vaccine (active)Both should be given togetherHuman rabies immunoglobulin: As much as possible of the dose should be infiltrated directly to wound, the remainder of the dose should be given intramuscularly (IM)Rabies vaccine should be given IM in opposite arm or thigh, the first dose immediately after exposure then repeated at days 3, 7, and 14. Immunocompromised persons get an additional dose at day 28

### Arboviruses (Arthropod-Borne Viruses) {#Sec42}

West Nile virus (WNV)Dengue fever

West Nile Virus {#Sec43}
---------------

**Background and epidemiology** The mostcommon neuroinvasive arboviral disease in the USATransmitted tohumans by *Culex* mosquitoesTransmission occurs from summer to fallCalifornia, North and South Dakota, Nebraska and Illinois were the most common locations in 2018Incubation 2--6 daysHumans also infected via transfusion and organ transplant**Clinical presentation** Most cases are asymptomatic (70--80%)May presentwith fever and flu-like symptomsFever, headache, myalgia, arthralgia, vomiting, diarrhea, transient rash\< 1% have neuroinvasive disease: Meningitis, encephalitis, acute flaccid myelitisWNV encephalitis: Altered mental status, seizures, paresis, nerve palsies, or coma in more severe casesMost recover completelybut can take months**Diagnosis** Anti-WNV IgM in serum or CSF may take a week to turn positive**Treatment** Supportive

Dengue Fever {#Sec44}
------------

**Background and epidemiology** Arbovirus transmitted by *Aedes* mosquitoesHistory of travel to endemic areaEndemic in Asia, Africa, Latin America, and Puerto RicoTransmission has occurred in Hawaii, Florida, and TexasIncubation period is 3--14 days**Clinical presentation** Can be asymptomaticFebrile illnesslasting 2--7 days: Pain in muscles, joints and bones, headache; retro-orbital pain, facial erythema, injected oropharynx, macularor maculopapular rash, leukopenia, petechiaeCritical phase: 24--48 h with plasma leakageConvalescent phase: Improvement and stabilizationSevere dengue (dengue hemorrhagic fever or dengue shock syndrome) occurs in 5% and can be deadlyIncreased risk for severe dengue with subsequent infection**Laboratory** During febrile phase,diagnose with PCR for viral DNA or immunoassay for nonstructural protein 1 (NS-1)From 3 to 5 days after onset, can test for anti-dengue IgMLeukopenia, thrombocytopenia, and modest elevation of liver enzymes**Treatment** Supportive

Human Papillomavirus (HPV) {#Sec45}
--------------------------

**Background and epidemiology** Most adultswill be infectedat some timeSchool-age children acquire nongenital hand and foot warts through minor skin traumaGenital transmission occurs skin-to-skinHPV causes most vulvar, vaginal, penile, and anal cancers; 70% of oropharyngeal cancersRare transmission to infant during deliveryIncubation period is months to yearsOncogenic strains 16 and 18 are responsible for two thirds of all cervical cancersNononcogenic HPV type 6 and 11 are responsible for \> 90% of anogenital warts**Clinical features** Most infections are subclinicalSkin warts are generally painless; plantar warts can be painfulAnogenital warts ( ) have cauliflower-like surface and can occur in groupsInvasive cancers linked to HPV include the following locations: Oropharynx, penis, anus, cervix, vagina, and vulvaSquamous intraepithelial lesions can be low or high grade due to persistent HPVCervical intraepithelial neoplasia (CIN) is precancerous and linked to HPVAdenocarcinoma in situ is anotherendocervical precancer**Immunization** 2 doses before 15th birthdayOnly 9-valent vaccine available in USA since 2017

Bacterial Pathogens {#Sec46}
===================

Gram-Positive Bacteria {#Sec47}
----------------------

*S. aureus* {#Sec48}
-----------

**Background and epidemiology** *S. aureus* is the most common cause of skin and soft tissue infection and musculoskeletal infection in healthy childrenSecond leading cause of healthcare-associated bacteremia (coagulase-negative staphylococci is first)Leading cause of secondary bacterial pneumonia in childrenMost common cause of healthcare-associated surgical site infectionsCoagulase positiveGrapelike clusters (Fig. [9.8](#Fig8){ref-type="fig"})*S. aureus* colonizes the nares and skin in 30--50% of childrenTransmitted by direct contact and indirectly from other patients in hospital settingsCan spray short distances into the air"Vancomycin-intermediately susceptible *S. aureus*" related to repeat vancomycin use in individuals. Vancomycin-resistant *S. aureus* rareIncubation period can be 12 hfor postoperative toxic shock syndrome**Common staphylococcal infections** Bullous and crusted impetigoSkin and soft tissue or lymph node infectionIf theorganism seeds the bloodstream, dissemination to joints, bones, kidney, liver, muscles, lungs, and heart valves may occur, causing substantial morbidity and potential mortality*S. aureus* is the most common cause of osteomyelitis, including sickle cell disease patients (who are also at increased risk for *Salmonella* osteomyelitis)Children with cyanotic congenital heart disease are at high risk of staphylococcal brain abscessChildren who undergo neurosurgical procedures, especially shunt revisions, are at high risk for staphylococcal infectionIndwelling bloodstreamcatheters can be associated with staphylococcal infection and must be removed if the patientdevelops symptoms or positive culture Fig. 9.8*Staphylococci* in blood culture (Gram stain, original magnification × 1000). The bacteria are Gram-positive cocci and grow in pairs, tetrads, and clusters (*arrow*). (Courtesy of M. Nawar Hakim, MD, Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA)

Folliculitis/Furunculosis/Carbunculosis (Fig. [9.9](#Fig9){ref-type="fig"}) {#Sec49}
---------------------------------------------------------------------------

**Background** Folliculitis: Superficial inflammation centered around a follicleFuruncles: Bacterial folliculitis of a single follicle that involves a deeper portion of the follicleCarbuncle: Bacterial folliculitis that involves the deeper portion of severalcontiguous folliclesBacterial folliculitis most often caused by *S. aureus*.Hot tub folliculitis is usually caused by Gram-negative bacteria (most *often P. aeruginosa;* self-limited)Usually the child looks healthy and does not appear illAbscess (\< 5 cm) drainage alone is curative without antibiotics and should be performed along with a request for culture**Management of skin and soft tissue infections** Indication for antibioticsThe child hashigh fever or other systemic symptomThe abscess is larger than 5 cmLocated in a critical location or in an area difficult to drainSigns and symptoms persist following incision and drainageCommon oral anti-staphylococcal antibioticsTrimethoprim--sulfamethoxazole (TMP-SMX) effectiveagainst most MRSACephalexin remains a good empiric choice for MSSA and group A *Streptococcus* (GAS) infectionsClindamycinDoxycycline (in children older than 8 years of age)Linezolid (for resistant MRSA infections not susceptible to TMP-SMXor clindamycin)Recurrent staphylococcal skin infections recommendationsEnhanced hygiene and environmental cleaningTreatment for anyone in the family who has active diseaseNasal and perianal mupirocinSkin decolonization (chlorhexidine and/or bleach baths)Treatment with antibiotic-based decolonization regimens (usually rifampin plus an additional agent) in selected cases Fig. 9.9(**a**) Furuncle: Erythematous tender papulonodule with central punctum with point of fluctuant. (**b**) Folliculitis: Superficial inflammation centered around a follicle, tender to touch

Toxic Shock Syndrome (TSS) {#Sec50}
--------------------------

**Background** Production of toxic shock syndrome toxin-1 (TSST-1)Can be caused by*S. aureus or S. pyogenes* (aka group A *Streptococcus* or GAS)**Risk factors** TamponSurgical implantsInvasive staphylococcal disease, including pneumonia and skeletal infectionNasal packingProgressive skin infection in cases caused by *S. pyogenes***Clinical presentation** FeverVomitingHypotension (abrupt onset)HypocalcemiaWatery diarrheaMyalgiaStrawberry tongueConjunctival hyperemiaRash with hand and foot desquamationBlood culture is usually negative if the cause is *S. aureus*Blood culture is usually positive if the cause is *S. pyogenes***Treatment** Vancomycin + clindamycin(stops toxin production) + nafcillin or oxacillin,pending culture resultsIn cases of tampon-associated TSS, must be removed immediately and the recommended length of therapy is 10--14 daysIV fluids and routine management of shock; consider IVIG for refractory shockDo not treat hypocalcemia unless symptomatic or electrocardiogram changesAnytime there is a postsurgicaltoxic shock, any device implanted during surgery must be removed immediately

Staphylococcal Scalded Skin Syndrome (SSSS) {#Sec51}
-------------------------------------------

**Background** SSSS(aka Ritter disease of the newborn)Ritter disease and staphylococcal epidermal necrolysis encompass a spectrum of superficial blistering skin disorders caused by exfoliative toxins of some strains of *S. aureus*SSSS differs from bullous impetigo; the exfoliative toxins are restricted to the area of infection in bullous impetigo, and bacteria can be cultured from the blister contentsExfoliative toxins cause separation of the epidermis beneath the granular cell layer. Bullae and diffuse sheetlike desquamation occursExotoxin is a protein and is classified as either type A or B. Most are type A**Clinical presentation** Fever, malaise, and irritabilityMost of the patients do not appear severely illTenderness to palpationDehydration may be present and can be significantNikolsky sign (gentle stroking of the skin causes the skin to separate at the epidermis)Bacteremia may or may not present**Diagnosis** Blood cultures are usually negative in children (but positive in bullous impetigo) and is usually positive in adultsA chest radiograph should be considered to rule out pneumonia as the original focus of infectionA biopsy of the affected area will demonstrate separation of the epidermis at the granular layer**Management** Fluid rehydrationis initiated with lactatedRinger solution at 20 mL/kg initial bolusRepeat the initial bolus, as clinically indicated, followed by maintenance therapy with consideration for fluid losses from exfoliation of skin being similar to a burn patientPrompt treatment with parenteral anti-staphylococcal antibiotics is essential

*S. aureus* Food Poisoning {#Sec52}
--------------------------

**Background** The most common cause of food poisoning in the USAEating contaminated food containing preformed enterotoxinUsually associated with meat, baked food filled with cream, and mayonnaiseIncubation period \< 4--6 h**Clinical presentation** Nausea, vomiting, and abdominal cramps in few hours after exposure to contaminated foodFever may be presentSome children can havesevere dehydration**Management** HydrationNo antibiotic required

Staphylococcal, Coagulase-Negative {#Sec53}
----------------------------------

**Background** and are examples of coagulase-negative staphylococci*S. epidermidis* is methicillin-resistant in most cases*S. epidermidis* is the most common cause of catheter-related bacteremiaCatheter becomes contaminated when passing through the skin*S. epidermidis* is a common contaminant in the blood cultures**Common source of infection** Skin, mucous membraneNosocomial infectionIV catheterVentriculoperitoneal shuntsProsthetic devices, e.g., heart valves, joints, and pacemakersBone marrow transplantPremature infants (intravascular catheter)**Management** Removal of theforeign body may be necessary to clear the infectionIn neonatal intensive care unit (NICU), positive culture must be initially treated if suspicious of infectionDraw two cultures from two different sites. To be considered positive, both cultures should be positive within 24 h.Vancomycin is the drugof choice

Methicillin-Sensitive *S. aureus* (MSSA) {#Sec54}
----------------------------------------

**Background** Most of *S. aureus* strains produce beta-lactamase enzyme and are resistant to penicillin and ampicillin**Drug of choice** Nafcillin or oxacillin (+ rifampin if indwelling foreign body)Treat for 3--4 days for bacteremia**Alternative drugs** CefazolinClindamycinVancomycinAmpicillin + sulbactam

Methicillin-Resistant *Staphylococcus aureus* (MRSA) {#Sec55}
----------------------------------------------------

**Background** MRSA strains are resistant to all beta-lactamase resistant (BLR) beta-lactam and cephalosporin antimicrobialsand other antimicrobial agents**Drug of choice in MRSA cases (oxacillin MIC, 4 ≥ μg/mL)** Vancomycin ± gentamicin or ± rifampin (multidrug resistance)For example, endocarditis,septicemia, and CNS infection (combination therapy is recommended)Alternative drugs in MRSA cases (multidrug resistance)Trimethoprim--sulfamethoxazoleLinezolidQuinupristin/dalfopristinDaptomycinTreat for 7--9 days for bacteremia**Community (not multidrug resistance)** Vancomycin ± gentamicin (or ± rifampin) for life-threatening infections, e.g., endocarditisClindamycin(if strain susceptible) for pneumonia, septic arthritis, osteomyelitis, skin, orsoft tissue infectionTMP-SMX for skin or soft tissue infectionsDaptomycin forvancomycin-intermediately susceptible *S. aureus*

*S. pneumonia* (Pneumococcal Infection) {#Sec56}
---------------------------------------

**Background and epidemiology** *S. pneumoniae* is a Gram-positive, catalase-negative, alpha-hemolytic bacteriumThe bacteria are Gram-positive diplococci (Fig. [9.10](#Fig10){ref-type="fig"})Introduction ofpneumococcal conjugate vaccines (PCV7 and PCV13) significantly reduce invasive pneumococcal disease in childrenNasopharyngeal carriage rates are 21% for industrialized countries to 90% in resource-limited settingsTransmission is person-to-person via respiratory droplets,occurring with viral upper respiratory infectionsMore common in winterIncubation period is 1--3 days**Risks of invasive pneumococcal disease** The highest age-specific attack rates occur during the first 2 years of lifeChildren who have sickle cell diseaseChildren who have aspleniaCongenital immunedeficienciesImmunosuppressive medications or bone marrow transplants also are at increased riskCSF leaks, e.g., neurosurgical procedures or skull fracturesCochlear implantsChronic heart orlung diseaseDiabetics**Clinical manifestations** Common pneumococcal infections include:Acute otitis mediaSinusitisPneumoniaBacteremia (most common manifestation of invasive pneumococcal disease)Meningitis (leading cause of meningitis)Pneumoniais the most common bacterial cause of community-acquired pneumonia in both children and adultsHigh fever and ill-appearingCough and tachypneaRespiratory distressCracklesDiminished breath soundsLobar consolidationmay be noted on chest radiography in older childrenKnow: Infants and young children may have bronchopneumonia with a scattered distribution of parenchymal consolidationPleural fluid may be evident in some patients**Diagnosis** Culture from blood or normally sterile body fluids such as CSF, pleural, synovial, or middle ear fluidPCR on blood or CSFspecimenPositive results should have antimicrobial susceptibility testing for penicillin, cefotaxime orceftriaxone, and clindamycin.**Treatment** **Outpatient otitis media:** Amoxicillin (80--90 mg/kg/day for \< 6 months and 6--23 months with bilateral disease) withwatch and wait 48--72 h for older children and nonsevere disease. Treat 10 days for severe disease. Treat 5--7 days for \> 6 years for mild or moderate disease. Alternate therapies include amoxicillin-clavulanate, cefdinir, cefpodoxime or cefuroxime or IM ceftriaxone × 3 doses. Samedosages for sinusitis if bacterial sinusitis diagnosed. If penicillin allergic type I (anaphylaxis), use clindamycinor levofloxacin**:** Amoxicillin (90 mg/kg/day)**Inpatient pneumonia**: Parenteral ampicillin. Alternatives: Cefotaxime and ceftriaxone**Pneumococcal meningitis:** Due toantibiotic resistance concerns, treatment of proven or suspected cases mandates empiric therapy with **or** while awaitingsusceptibility results. Discontinue vancomycin if susceptible to penicillin, cefotaxime, or ceftriaxone**Other invasive pneumococcal infections, inpatient:** Same as for pneumococcal meningitis Fig. 9.10(pneumococci) in blood culture (Gram stain, original magnification × 1000). The bacteria are Gram-positive diplococci (*arrows*). They are often lancet-shaped. (Courtesy of M. Nawar Hakim, MD, Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA) Fig. 9.11Streptococci in bloodculture (Gram stain, original magnification × 1000). The bacteria areGram-positive cocci and grow in chains (*arrow*). (Courtesy of M. Nawar Hakim, MD, Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA)

Streptococcus pyogenes {#Sec5700}
----------------------

Group A Streptococcus (GAS) is a Gram-positive bacterium that grows in chains (Fig. [9.11](#Fig11){ref-type="fig"})

Group A Beta-Hemolytic Streptococcus (GAS) Pharyngitis {#Sec57}
------------------------------------------------------

**Background and epidemiology** Causes pharyngitis and impetigoPharyngitis: Transmits via contact with respiratory tract secretions of infected personImpetigo: Transmits via directcontact from another personIncreased risk for pharyngitis and impetigo with crowdingMost often in schools, childcare centers, contact sportsSome are chronic pharyngeal carriersIncreased risk of invasive GAS infection in infants and elderlyLike *S. aureus*, can cause TSSRheumatic fever can develop in about 3% of untreated patients with GAS pharyngitisIncubation period for GAS pharyngitis is 2--5 days; for GAS impetigo is 7--10 daysFor TSS, can occur 14 h afterinoculation of organism (e.g., trauma)**Clinical presentation** Sore throat, fever, headache, and abdominal pain the most classic presentationNausea and vomiting may occurPharyngeal erythema and palatal petechiae (Fig. [9.12](#Fig12){ref-type="fig"})Inflammation of the uvulaAnterior cervical lymphadenopathyTonsillar exudatesmay or may not be present**Diagnosis** Rapid antigen detection test ishighly recommended to decrease overuse of antibioticsTesting of asymptomatic household contacts not recommended except when contacts are at increased risk of developing sequelae of GAS infection, e.g., rheumatic fever, post-streptococcal glomerulonephritis, or TSSIf rapid antigen detection test (RADT) positive, treat (specificity of 95%)If RADT is negative, do throat culture (sensitivity of 65--90%)Treatment of GAS sore throat as long as 9 days after the onset of symptoms still effectively preventsrheumatic fever; initiation of antibiotics is seldom of urgent importance**Treatment** Reduces complicationsDecreases the duration of infectionReduces transmission to othersOral penicillin VK (250--500 mg twice to three times a day for 10 days) is the antibiotic treatment of choice for GAS pharyngitisAmoxicillin (50 mg/kg, maximum 1 g, once daily for 10 days) often is used instead of oral penicillin because of its more palatable liquid formulationCephalosporins or macrolides may be used as first-line therapy in patients allergic to beta-lactam antibiotics but otherwise are not recommended as first-line therapyIM benzathine penicillin G 600,000 U for children who weigh \< 27 kg and 1.2 million U for heavier children as a single dose (if adherence is a problem but is painful)Know: Treatment is indicated if a GAS carrier develops an acute illness consistent with GAS pharyngitis**Treatment to eradicate GAS carriage indications** History ofacute rheumatic feverClose contact who has a history of rheumatic feverFamilies experiencingrepeated episodes of GAS pharyngitisEradication regimens include clindamycin, cephalosporins, amoxicillin--clavulanate Fig. 9.12Streptococcal pharyngitis: Palatal petechiae, rapid strep was positive in this patient

Scarlet Fever (Scarlatina) {#Sec58}
--------------------------

**Background** Syndrome characterized by exudative pharyngitis, fever, and scarlatiniform rashCaused by toxin-producing GASfound in secretionsand discharge from the nose, ears, throat, and skin**Clinical presentation** Fever may be presentPatient usually appears moderately illOn day 1 or 2, the tongue is heavily coated with a white membrane through which edematous red papillae protrude (classic appearance of white strawberry tongue) (Fig. [9.13](#Fig13){ref-type="fig"})By day 4 or 5, the white membrane sloughs off, revealing a shiny red tongue with prominent papillae (red strawberry tongue)Red, edematous, exudative tonsillitisDiffuse, erythematous, blanching, fine papular rash that resembles sandpaper on palpation (Fig. [9.14](#Fig14){ref-type="fig"})The rash is prominent especially in the flexor skin creases of the antecubital fossa and axillae (Pastia lines, which are pathognomonic for scarlet fever)Circumoral pallorDesquamation after the rash starts tofade (usually the rash lasts about 1 week)**Diagnosis** Throat culture or rapid streptococcaltestAnti-deoxyribonuclease B and antistreptolysin O titers (anti-DNase B and ASO, antibodies to streptococcal extracellular products)**Management** Penicillin remains the drug of choice (documented cases of penicillin-resistant group A streptococcal infections still do not exist)First-generation cephalosporin may be an effective alternative**Streptococcosis** Occurs in children younger than 3 yearsYoung infants may not present with classic pharyngitisLow-grade feverThick purulentnasal dischargePoor feedingAnterior cervical lymphadenopathySome patients may be toxic with high fever,malaise, headache, and severe pain upon swallowing Fig. 9.13Strawberry tongue with white coat in a child with scarlet fever Fig. 9.14Scarlet fever: Fine erythematous punctate eruption with dry, rough texture to the skin that resembles the feel of coarse sandpaper and scarlet macules overlying the generalized erythema

Impetigo {#Sec59}
--------

**Background** GAS impetigois a superficial bacterial skin infection (small percentage)In North America the etiologic agent is primarily *S. aureus***Clinical presentation** Common (i.e., crusted or nonbullous) impetigo: Initial lesion is a superficial papulovesicular lesion that ruptures easilyThe lesionbecomes purulent and covered with an amber-colored crust (Fig. [9.15](#Fig15){ref-type="fig"})Bullous impetigo: Superficial fragile bullae containing serous fluid or pus form andthen rupture to form round, very erythematous erosionsThe lesions usually located in exposed areas, especially the face and extremitiesLesions usually often spread due to autoinoculation**Treatment** Topical mupirocin or retapamulin for localized lesionsMultiple localized lesions may require systemic treatment such as cephalexinor clindamycinthat covers both GAS and staphylococcal infectionsShould not go back to school until at least 12 h after beginning appropriate antimicrobialPatient should avoidclose contact with other children if possible Fig. 9.15(**a**) Impetigo: Honey-crusted lesions under the nostril and on the cheek. (**b**) Impetigo: Honey-crusted lesions on the arm and trunk

Perianal Bacterial Dermatitis (Formerly Called Perianal Streptococcal Dermatitis) {#Sec60}
---------------------------------------------------------------------------------

**Background** May becaused by *S.* *pyogenes* (GAS) or *S. aureus*, occurring in children 6 months--10 yearsOften misdiagnosed and treated inappropriatelyEarly antibiotic treatment results in dramatic and rapid improvement in symptoms**Clinical presentation** Perianal rash,itching, and rectal pain; blood-streaked stools may also be seen in one-third of patientsBright red, sharply demarcated rash around the anal area (Fig. [9.16](#Fig16){ref-type="fig"})**Diagnosis** A rapidstreptococcal test of suspicious areas can confirm the diagnosis if etiology is GAS (vast majority of cases)Routine skin culture is an alternative diagnostic aid**Management** Treatment with empiric oral cephalexinis effective for most staph and strep;if rapid strep is positive, can use oral penicillin or amoxicillinTopical mupirocin three times per day for 10 daysFollow-up is necessary because recurrences are common Fig. 9.16Perianal bacterial dermatitis: 4-year-old presents with rectal pain, itchiness, and discomfort when sitting; physical exam shows bright red, sharply demarcated rash around the anal area. Strep test was positive

Erysipelas GAS {#Sec61}
--------------

**Clinical presentation** Erythema and edemaSharply defined and elevated border tender to palpationSystemic signs such as fever are often presentLymphangitis may occur**Management** Systemic antibiotictherapy is requiredParenteral antibioticsmay be needed, especially in immunocompromised patients

Streptococcal Toxic Shock Syndrome {#Sec62}
----------------------------------

**Background** GAS TSS is a form of invasiveGAS disease associated with the acute onset of shock and organ failure**Risk factors** Injuries resulting in bruising or muscle strainSurgical proceduresVaricella infectionNSAID useStreptococcal exotoxins that act as superantigens cause release of cytokines leading to capillary leak,leading tohypotension and organ damage**Clinical presentation** FeverAbrupt onset of severe pain, often associated with a preceding soft-tissue infection, e.g., cellulitis or osteomyelitisKnow: Patient may be normotensive initially, but hypotension develops quicklyErythroderma, ageneralized erythematous macular rash, may develop**Diagnosis** Leukocytosis with immature neutrophilsElevated serum creatinine valuesHypoalbuminemiaHypocalcemiaElevated creatine kinase concentrationMyoglobinuria, hemoglobinuriaPositive blood culturesDiagnosis of GAS TSSrequires isolation of GAS, e.g., blood or CSF**Treatment for GAS TSS** Aggressive fluid replacement is essential to maintain adequate perfusion to prevent end-organ damageVasopressors also may be requiredImmediate surgical exploration and debridement are necessary, and repeated resections may be requiredEmpiric therapy with broad-spectrum IV antibiotics to cover both streptococcal and staphylococcal infections, e.g., clindamycinIV plus penicillin G IVImmune globulin intravenous (IGIV) alsomay be used as adjunctive therapy

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections (PANDAS) {#Sec63}
-------------------------------------------------------------------------------------------------

**Background** PANDAS describes a group of neuropsychiatric disorders, in particular, obsessive compulsive disorder (OCD), tic disorders, and Tourette syndrome, that are exacerbated by GAS infectionDiagnostic criteria for PANDAS include:Tourette syndrome; abrupt onset in childhoodRelationship between GAS infection and episodic symptoms confirmed by RADT, throat culture, skin culture, or serologic testingEvaluation for GAS infection should be considered in childrenwho present with the abrupt onset of OCD or tic disorder**Management** Treatment of theGAS infection and neuropsychiatric therapyBehavioral therapy and pharmacological therapies, including:Selective serotonin reuptake inhibitors (SSRIs) for OCDClonidine for tics

Necrotizing Fasciitis {#Sec64}
---------------------

**Background** A form of invasive bacterial disease that is often polymicrobial. This infection is characterized by extensive local necrosis of subcutaneous soft tissuesTypically caused by GAS and/or mixed aerobic and anaerobic flora, including *Clostridium, Staphylococcus.* Salt water necrotizing fasciitis contains *Vibrio species*. Freshwater necrotizing fasciitis contains *Aeromonas***Clinical presentation** Fever, hypotension, malaise, and myalgiasRapidly increasingpain; erythematous skin that progresses to blisters, bullae, and crepitus with subcutaneous gas**Laboratory findings** Leukocytosis with a predominance of neutrophilsElevated creatine kinase, lactate, and creatinine valuesPositive wound cultures**Diagnosis** Diagnosis isclinical and requiresa high degree of suspicion because of the rapid progression of infection**Treatment** Early and aggressive surgical exploration and debridementTriple antibiotic therapy with IV penicillin G, clindamycin, and an aminoglycoside is recommendedHemodynamic support if GAS TSS is presentRepeat surgery is necessary until all necrotic tissue has been removedAntibiotic therapy should continue for several days after completion of surgical debridement and may include penicillin G, vancomycin, metronidazole, or imipenem/meropenem

*Listeria monocytogenes* {#Sec65}
------------------------

**Background** Aerobic Gram-positive bacillusRare diseasewith case fatality of 16--20%Mode of transmission is mostly foodborneUnpasteurized milk and soft cheesesUndercooked poultryDeli-style, prepared meatsAsymptomatic vagina carrier in pregnant women**Clinical presentation** Neonatal early onsetinfection \< 7 days causes preterm birth, sepsis, or pneumonia with 14--56% fatality. Characteristic rash with papulesNeonatal late onset infection \> 7 days causes meningitis with 25% fatality**Treatment** Ampicillin and aminoglycoside

*Corynebacterium diphtheriae* {#Sec66}
-----------------------------

**Background** Gram-positive pleomorphic bacillusHumans arereservoirsRare due to immunization**Clinical presentation** Low-grade feverSore throatMalaiseDifficulty swallowingBilateral cervical lymphadenopathy ("bull neck")Grayish exudates overmucous membraneBleeding after attempting to remove the membraneDiphtheria toxins can cause myocarditis, necrosis, and peripheral neuritis**Treatment** If diphtheria is suspected,antitoxin (equine hyperimmune antiserum IV) should be started immediately to neutralize the toxins. Administer erythromycin for 14 days also.Know: Close contacts should receive single IM dose of penicillin G benzathine or oral erythromycin regardless of theirimmunization status.

Enterococcus {#Sec67}
------------

**Background** Gram-positive cocciNormal inhabitant of the GI tractandMost neonatal enterococcal infections are nosocomial and occur after 2nd week of life, usually with bacteremia due to line infection or necrotizing enterocolitis (common symptoms in neonates include, fever, bradycardia, apnea, and abdominal distention)**Associated infections** Bacteremia in neonatesCatheter- associated bacteremiaEndocarditisIntra-abdominal abscessUTI**Antibiotics** Resistant to all cephalosporins and vancomycin*E. faecalis* is susceptible to ampicillin*E. faecium* is resistant to ampicillin. Treat with vancomycin pending susceptibility results unless vancomycin-resistant *enterococcus* (VRE), which requires linezolidSensitivity testing is imperative because of resistanceSensitive enterococcal sepsis or endocarditismust be treated with penicillin, ampicillin, or vancomycin + gentamicin

*Bacillus anthracis* {#Sec68}
--------------------

**Background** Large positive rods (bacilli) that cause anthraxTypes ofanthrax: Cutaneous anthrax, pulmonic, and GIInoculation occurs from handling contaminated substance, e.g., wool, and in cases of bioterrorism, via mail**Clinical presentation** Painless papules and ulcersPainless black eschar withpainless swelling and induration**Treatment** Penicillin G or quinolones, e.g., ciprofloxacin

*Bacillus cereus* {#Sec69}
-----------------

**Background** Soil-dwelling, Gram-positive rods, beta hemolytic bacteriumProduces GI symptoms due to enterotoxin production in vivo in the GI tract**Clinical presentation** Vomiting withincubation period 1--6 h (the emetic form is commonly associated with fried rice left at room temperature)Diarrhea withincubation period 8--16 hEye infection after traumatic eye injuries in contact lens wearers**Diagnosis** Usually clinical*B. cereus* spores instoolIsolated toxins from suspected food items**Treatment** Self-limited and requires no antibiotics

*Arcanobacterium haemolyticum* {#Sec70}
------------------------------

**Background** *A. haemolyticum* can be mistaken with strep pharyngitis or scarlet feverGram-positive bacillusGrows slowly assmall colonies with narrow bands of hemolysis on blood-enriched agarGrowth enhanced by culture on rabbit or human blood with incubation in 5% CO2**Clinical presentation** Common in teenagers and young adults0.5--3% of acute pharyngitisExcept for absenceof palatal petechiae and strawberry tongue, the disease indistinguishable from that caused by groupA *Streptococcus*FeverPharyngeal exudatesCervical lymphadenopathyScarlatiniform or maculopapular pruritic rash in 50% of cases; usually spares the palms and soles**Treatment** Macrolides : Erythromycin or azithromycin

Anaerobes {#Sec71}
=========

*Clostridium botulinum* {#Sec72}
-----------------------

**Background** *C. botulinum* is an anaerobic Gram-positive rod that survives in soil and marine sediment by forming sporesHuman botulismis caused byneurotoxins A, B, E, and, occasionally, F

Infant Botulism {#Sec73}
---------------

Ingestion of honey or exposure to contaminated soils increases the riskAge between 3 weeks and 6 monthsSymptoms develop 3--30  days from the time of exposure**Clinical presentation** Constipation usually the initial findingFeeding difficulty isa common presenting symptomHypotoniaIncreased droolingWeak cryTruncal weaknessCranial nerve palsiesGeneralized weakness with ventilatory failure**Diagnosis** Stool toxin detection**Treatment** Botulism immune globulin (BIG) IV should be started as early as possible if clinically suspectedAntibiotics (gentamicin) canpotentiate toxin paralyticeffect

Foodborne Botulism {#Sec74}
------------------

**Background** Most common source is home canned foodSymptoms develop 12--36 h after toxin ingestionWound botulism is similar, except the incubationperiod between 4 and 14 days**Clinical presentation** Initial symptoms: Dry mouth, nausea, and diarrheaBilateral cranial nerve palsiesEye diplopia and blurring visionDysphagiaUpper extremity weaknessRespiratory dysfunctionLower extremity dysfunction**Treatment of botulism in older patients** Equine trivalent antitoxin (types A, B, and E)Wound debridement for wound botulismis recommended

*Clostridium perfringens* {#Sec75}
-------------------------

**Background** Gram-positive , rod- shaped, anaerobic, spore-forming bacteriumSpores found in raw meat and poultryIncubation period 8--12 h**Clinical presentation** Sudden onset of diarrheaCrampy abdominal pain**Management** Resolves within 24 hRehydration

*Clostridium tetani* {#Sec76}
--------------------

**Background** *C. tetani,* an obligate anaerobic Gram-positive bacillus, is the pathogen responsible for tetanusNonencapsulated and forms spores that resist heat, desiccation, and disinfectantsContaminated deep puncture wounds, open wounds, soil, and animals (wool) containing spores are the most commonsources of this bacteria**Neonatal tetanus** Contaminated umbilical cord is a common source of infectionPoor feeding (poor suck andswallowing due to muscle spasm)Constant cryingDecreased movementSpasm and rigidity**Generalized tetanus** Trismus (lockjaw)Sardonic smile (*risus sardonicus*)Severe muscle spasmOpisthotonos (severe hyperextension)Laryngeal spasm can lead to airway obstruction and deathTetanic seizure is severe; tonic contractions with high feverDiagnosis is always clinical**Treatment** Human tetanus immune globulin immediatelyPenicillin G or metronidazoleMuscle relaxants**Prevention of tetanus** Routine immunization with DTaP and Tdap**Prevention in wound injuries guideline** Tetanus vaccine +/− tetanus immunoglobulin (TIG)Dirty wound, immunization is unknown or less than three tetanus shots: Give TIG + tetanus vaccineDirty wound, immunized \> 5 years and \< 10 years: Immunize, no TIGDirty wound, immunized \< 5 years: No treatmentClean wound, immunized \< 10 years: No treatmentClean wound,immunized \> 10 years: Immunize, no TIG

*Clostridium difficile* {#Sec77}
-----------------------

**Background** Gram-positive anaerobesColonizationAround 50% of infants younger than 1 year are colonizedCarriage decreases by 1--5% by 2 years of ageRisk factors:Having infected roommate or having symptomatic patient in the samewardAntibiotics, e.g., beta-lactams drugs, clindamycin, and macrolidesUnderlying bowel disease or surgeriesSymptomatic disease is due to toxins A and B produced by the organism**Clinical presentation** Asymptomatic colonization is common in infants and young childrenWatery diarrheaAbdominal crampsAbdominal tendernessIn severe cases:Systemic toxicityBloody diarrheaToxic megacolon, perforation, or even death are complications of pseudomembranous colitis**Diagnosis** Documenting toxin A and Bin stool using PCR or nucleic acid amplification tests (NAATs) (for toxin genes)Endoscopic findings of pseudomembranous enterocolitisYoung children \< 2 years are commonly colonized with *C. difficile***Treatment** Initial episode,non-severe: Oral metronidazoleOral vancomycin with or without metronidazolecan be used in severe casesRecurrence: Oral vancomycin can be used alone or with rifaximin, or fecal microbiota transplantation**Prevention** Hand washing with water and soapKnow: Alcohol-based product are not effective against the organismDiluted bleach solution is the best for decontamination of surfacesLimit antibiotic useInfected children should be excluded fromchildcare facility for the duration of diarrhea

Gram-Negative Bacteria {#Sec78}
======================

Gram-Negative Anaerobes {#Sec79}
-----------------------

BacteroidesFusobacterium anaerobes**Causes a variety of clinical manifestations depending on the location** Head and neckRetropharyngeal abscessPeritonsillar abscessDental abscessLudwig anginaCNSBrain abscessSubdural and epidural empyemaLungAspiration pneumoniaLung abscessPleural empyemaAbdomenPeritonitisAppendicitisIntra-abdominal abscessSkin and soft tissueInfected bite woundNecrotizing fasciitisCellulitisAntibiotics with anaerobic activityClindamycinPenicillinAmpicillin--sulbactamAmoxicillin--clavulanic acidMetronidazole

*Campylobacter* Species {#Sec80}
-----------------------

**Background and epidemiology** *Campylobacter jejuni* (Gram-negative motile bacilli)One of the most common agents associated with bacterial gastroenteritisCommon sources:Uncooked poultry (chicken and turkey), unpasteurized milk, dogs and catsIncubation period: 2--5 days**Clinical presentation** Bloody diarrheaAbdominal pain(may mimic inflammatory bowel disease in severe cases)TenesmusFever**Diagnosis** Stool culture in a selective media attemperature 42 °C incubated in gas mixture O2 and CO2**Treatment** Azithromycinand erythromycin shorten illness duration and prevent relapse

*Chlamydia pneumoniae* {#Sec81}
----------------------

**Background and epidemiology** Transmitted from one person to another via respiratory secretions50% of adults haveantibody evidence of exposure**Clinical presentation** Patient may be asymptomatic or mildly to moderately illIllness is usually prolonged with cough persisting for 2--6 weeksPneumonia and pulmonary ralesAcute bronchitis and bronchospasmLess commonly: Nonexudative pharyngitis, laryngitis, otitis media, and sinusitis**Diagnosis** Fourfold increase in IgG titer from acute to convalescentIgM titer of ≥ 1:16Cross-reactivity and persistent antibody makes diagnosis problematic**Treatment** Macrolides, doxycycline , or tetracycline

*Chlamydophila psittaci* {#Sec82}
------------------------

**Background** *C. psittaci* is obligate intracellular bacterial pathogenBirds aremajor reservoir of *C. psittaci*, e.g.,parakeets and parrotsAnimals such as goats and cows may become infected**Clinical presentation (psittacosis)** FeverNonproductive coughHeadacheMalaiseExtensive interstitial pneumonia can occurPericarditis, hepatitis, and encephalitis (rare)**Diagnosis** Serology, nucleic acid amplificationtests, PCR**Treatment** Doxycyclinepreferred therapy, including children \< 8 yearsMacrolides for pregnant women

Conjunctivitis Due to *Chlamydia trachomatis* {#Sec83}
---------------------------------------------

**Background and epidemiology** The most frequently identified infectious cause of neonatal conjunctivitisTransmitted perinatally from infected mothers**Clinical presentation** The symptoms typically develop 5--14 days after birthConjunctival edemaHyperemiaWatery-to- mucopurulent dischargeA pseudomembrane may form and bloody discharge may be present if infection is prolonged**Management** Oral erythromycin × 14 days or azithromycin× 3 daysKnow: Topical prophylaxis with erythromycin or silver nitrate given to all infants to prevent neonatal gonococcal conjunctivitis is *ineffective* against chlamydial conjunctivitis. Suctioning may increase comfort and improve feeding.

Pneumonia Due to *C. trachomatis* {#Sec84}
---------------------------------

**Background** Small, Gram-negative, obligate intracellular organismsTransmitted to the infant from the birth canalGenerally presents as a subacute infection 2--19 weeks after birth**Clinical presentation** Rhinorrhea, congestion, or conjunctivitisTachypneaStaccato coughCrackles (rales)Wheezing (rare)Preterm infants may have episodes of apnea**Diagnosis** Chest radiography reveals infiltrates and hyperinflationLaboratory testing may reveal:Peripheral eosinophiliaElevated serum immunoglobulinsA positive NP directfluorescent antibody (DFA) test or culture is considered diagnostic**Treatment** Antibiotic treatment should be started presumptively on clinical groundsSame antibiotic regimens as for neonatal conjunctivitisIf untreated, symptoms can last for months and include persistent hypoxemiaRemember: Diagnosis of chlamydial pneumonia in an infant necessitates treatment of the infant's mother and her sexual partner

Chlamydia Genitourinary Tract Infection {#Sec85}
---------------------------------------

**Background** Sexual transmission**Clinical presentation** Females: Vaginitis inprepubertal girls, urethritis, cervicitis, endometritis, salpingitis, proctitis, and perihepatitis (Fitz--Hugh--Curtis syndrome). Can progress to pelvic inflammatory diseaseMales: Urethritis, epididymitis, and proctitisReiter syndrome (arthritis, urethritis, bilateral conjunctivitis)*Lymphogranuloma venereum* (LGV): Ulcerative lesion on genitalia followed by tender, unilateral lymphadenopathy**Diagnosis** NAATs of vaginal,endocervical, and male intraurethral specimens; urine specimens**Treatment** Doxycycline100 mg per os BID for 7 daysAzithromycinsingle dose 1 g

Trachoma {#Sec86}
--------

**Background** Chronic keratoconjunctivitis caused by the obligate intracellular bacterium *C. trachomatis*Disease transmission occurs primarily between children and the women who care for themTrachoma is the mostcommon infectious cause of blindness worldwide**Clinical presentation** Chronic follicular keratoconjunctivitis with corneal neovascularization resulting from untreated or chronic infectionBlindness occurs in up to 15% of those infectedTrachoma rarely occurs in the USA**Diagnosis** Clinical diagnosis and NAATs can confirm the causative agentThe cicatricialphase has unique clinical features (eyelid scarring, eyelid buckling, lashes rubbing on eye), which lead to definitive diagnosis in most cases**Treatment** Azithromycin single dose 20 mg/kg

*Neisseria gonorrhoeae* (Gonococcal Infections) {#Sec87}
-----------------------------------------------

**Background** *N. gonorrhoeae* is a Gram-negative diplococcusGonococcal infection is the second most common bacterial disease in the USA classified as nationally reportable and notifiableHighest prevalence in youth, especially females between 15 and 19 years of ageThe incubation periodis 2--7 daysA child abuseevaluation must be performed in any prepubertal case**Neonatal conjunctivitis** Conjunctivitis due to mucosal transmission during vaginal deliveryTopical antibiotics (erythromycin, silver nitrate, or tetracycline) to the eyes of a newborn within 1 h of birth [can]{.ul} prevent the infectionTreatment isceftriaxone 125 mg IM × 1**Gonococcal pharyngitis** Genital--oral activity is the major riskInfection isasymptomatic in most casesPatients who have gonococcal pharyngitis have a significant public health impactGonococcal pharyngitis patients at risk for developing disseminated gonococcal infection (DGI)Pharyngeal infection clears spontaneously within 12 weeksTreatment isceftriaxone 250 mg IM × 1**Gonococcal urethritis** Dysuria and a mucopurulent penile dischargeMay becoinfected with other sexually transmitted organisms, most commonly, *C. trachomatis*Positive leukocyteesterase usually seen in urine specimenDiagnosis of gonococcal urethritis with NAATsPresence of intracellular diplococci in urethral dischargeTreatment isceftriaxone 250 mg IM × 1 plus azithromycin1 g × 1**Epididymitis (gonococcus)** Dysuria and a mucopurulent dischargeScrotal edema with scrotal, inguinal, or flank painUrinalysis may demonstrate WBCsIn most cases this infection is transmitted sexually and may be an extension of urethritis**Gonococcal proctitis** Most cases of proctitis due to *N. gonorrhoeae* occur in homosexual malesClinical presentationAnal dischargeRectal bleedingAnorectal painTenesmusConstipation**Disseminated gonococcal infection (DGI)** DGI infection occurs in 0.5--3% of people infected with *N. gonorrhoeae*DGI usually causes an asymptomatic genital infectionMigratory arthritis(wrist, ankle, and knee) are the most common locationsDermatitisTenosynovitisFever and chills may occurElevated WBC countDGI occurs more commonly in females**Screening methods for infection** ***N. gonorrhoeae*** **and** ***Chlamydia*** Culture is the gold standard for diagnosing *C. trachomatis*Standard collection sites include the endocervix, male and female urethra, nasopharynx,conjunctiva, vagina, and rectumNAATs amplify nucleic acid sequences specific for the organism of interestThe ease ofurine collection, together with the high sensitivity of NAATs, has made these tests the preferred method for screeningThe presence of Gram-negative intracellular diplococci on microscopy suggests the diagnosis of gonococcalinfection

*N. meningitidis* (Meningococcal Infections) {#Sec88}
--------------------------------------------

**Background** Aerobic Gram-negative diplococcus *N. meningitidis*Natural commensal organism living in the nasopharynx of humansChildren younger than2 years of age have a nearly fivefold greater risk of contracting meningococcal disease than the general adult populationRisk of transmission: Crowded living conditions, e.g., college dormitories, military barracks**Clues to investigate for invasive meningococcal infection** RashAny rashappearing in the context of a sudden febrile illness should raise concernMeningococcal rash is typically present within 24 h of any symptomatologyPetechiae may be intraoral or conjunctival or be hidden in skinfoldsEarly rash may not be petechialTrue rigorsShaking chills that cannot be stopped voluntarilyProlonged (10--20 min)Neck painSevere pain in the neck, back, or extremitiesMay manifest in younger children as refusal to walkMeningismus: In patients older than 3 years, the classic signs of Kernig and Brudzinski may be elicitedVomitingMay be associated with headache or abdominal pain without diarrheaCushing triad:BradycardiaHypertensionRespiratory depressionPurpura fulminans (meningococcemia)Aggressive spread of purpura to large areas with ischemic necrosisSudden drops in blood pressureAcute adrenal hemorrhage( Waterhouse--Friderichsen syndrome)**Diagnosis** Culture of the organism from a normally sterile site is the gold standard for bacteriologicaldiagnosisCSF study:CSF WBC countsare elevated in most patients who have meningitisCSF WBC counts are low or even normal if the disease is severe and rapidly progressiveMarkedly low glucose and elevated protein values are associated with the diagnosis of meningitisAll patients with meningococcal disease or meningitis must be tested for CH50 or CH100 assay (20% of childrenwith meningococcal disease will end having a complement deficiency)**Management** Know: Antibioticsand fluids should not be delayedPenicillin iseffective treatment for both severe meningococcal septicemia (SMS) and meningococcal meningitis if the diagnosis is certainBroad-spectrum antibiotics effective against *N. meningitidis* and other potential pathogens are indicated (e.g., ceftriaxone, cefotaxime, and vancomycin)Emergency care evaluation and preferably transported via emergency medical services to allow for prompt delivery of IV fluids and airway management if the condition is suspectedLarge isotonic fluid boluses (20 mL/kg) over the first 5 minInotropic/vasoactive agent such as dopamine or dobutamineHydrocortisone may be beneficial in childrenrespond poorly to vasopressors**Prevention and indications for meningococcal vaccines** MenACWY vaccine is routinely recommended at 11--12 years of age; 2 vaccines licensed for children and adults,1 doseCan give as young as 2 months as a 4-dose series for high risk (complement deficiency, asplenia, HIV, travel to endemic area)MenB vaccine is optional and preferred for 16--18 years of age, 2-dose seriesCan give as young as 10 years for high risk (complement deficiency, asplenia, outbreak, lab workers); 2- or 3-dose series for high riskAntibiotic prophylaxis, e.g., rifampin, ciprofloxacin, azithromycin, or ceftriaxone should be used for contacts:Childcare contactDirect exposure to oral secretions of individuals with meningococcal disease (such as personnel providingmouth-to-mouth resuscitation)

*Haemophilus influenzae* {#Sec89}
------------------------

**Background** Pleomorphic Gram-negative coccobacillus spread via respiratory tract secretionsFormerly the most common cause of meningitis and serious bacteremia in childrenIntroduction of the *H. influenzae* vaccine quickly reduced the incidence of encapsulated *H. influenzae* type bNontypeable strains are still responsible for a large number of mucosal infections, including conjunctivitis, otitis media, sinusitis, and bronchitis**Bacterial meningitis** Peak age is less than 1 yearMortality rate around 5%Common complications include: Subdural empyema, brain infarct, cerebritis, ventriculitis, brain abscess, and hydrocephalusLong-term sequelae occur in 15--30% of survivors with sensorineural hearing loss; others includelanguage disorders, intellectual disability, and developmental delayDexamethasone before or with antibiotics such as ceftriaxone or cefotaxime to prevent hearing loss and neurologic sequelae**Epiglottitis** Hib was thepredominant organism (\> 90%) in pediatric epiglottitis before vaccine introduction. Since that time, other bacteria, including *S. pneumoniae*, GAS, *S. aureus*, and *Moraxella catarrhalis,* can cause epiglottitisOccurs primarily inchildren aged 2--7 years.The clinical triad of drooling, dysphagia, and distress is the classic presentationFever with associated respiratory distress or air hunger occurs in most patientsTreatment in patients with epiglottitis is directed toward relieving the airway obstruction and eradicating the infectious agentOptimally, initial treatment is provided by a pediatric anesthesiologist and either a pediatric surgeon or apediatric otolaryngologist**Buccal infections** Buccal cellulitis previously was always caused by *H. influenzae* infection before the vaccineAlways associated with bacteremia if presentPresent with palpable cellulitis on both checks, purplish in color, and child looksvery toxic**Periorbital cellulitis** Previously *H. influenzae* was a common cause, now *S. pneumoniae* bacteria is the most common etiology associated with sinusitisMinor trauma or insect bite of the eyelid usually associated with preseptal cellulitis due to *S. aureus* or a Group A *Streptococcus***Pyogenic arthritis** *H. influenzae* was themost common cause of septic arthritis in children lessthan 2 years of agebefore Hib vaccine**Occult bacteremia** Occult bacteremia with *H. influenzae* will result in in 30--50% developing meningitis or other deep orfocal infection from occult bacteremiaAll occult bacteremiafrom *H. influenzae* has to be treated immediately**Pneumonia** Pneumonia from *H. influenzae* used to cause about one-third of bacterialpneumonia before Hibvaccine and was associated with pleural effusion and positive blood culture in most cases**Treatment (in patient with life-threatening illness)** Remember: The organism produces beta lactamase, which makes amoxicillin ineffectiveCefotaxime or ceftriaxone is theantimicrobial of choiceMeropenem or chloramphenicol is another optionAmoxicillin is the drug of choice for noninvasive diseases such as otitis media or sinusitis; if amoxicillin fails, uses antibiotics against beta-lactamase-producing strains, e.g., nontypeable *H. influenzae* including amoxicillin/clavulanate, TMP-SMX, azithromycin, cefuroxime axetil, cefixime, andcefpodoxime.**Rifampin antibiotic prophylaxis for contact with invasive Hib infection** All members of household who did not receive immunizationLess than4 years with incomplete immunizationYounger than 12 months who did not complete primary Hib immunizationImmunocompromised childNursery school and childcare center if two or more cases within 60 days (outbreak)

*Mycoplasma pneumonia* {#Sec90}
----------------------

**Background** *M. pneumoniae* is the leading cause of pneumonia in school age children and young adultsInfection isprevalent in persons living in group setting[Incubation]{.ul} period is 2--3 weeks**Clinical presentation** Pulmonary manifestationsNonproductive coughChillsScattered ralesSkin rashBilateral infiltrate on chest radiographExtrapulmonary manifestationsPharyngitisRashStevens--Johnson syndromeHemolytic anemiaArthritisCNS disease (encephalitis; cranial nerve palsy, especially CN III)**Testing for mycoplasma** Mycoplasma DNA PCR nasal washingIgG and IgMserology or cold agglutinin**Treatment** Mycoplasma lacks the cell wall and beta lactams are not effectiveAzithromycin is the drug of choice

*Pasteurella multocida* {#Sec91}
-----------------------

**Background** Small Gram-negative coccobacilli; normal oral flora in animals, e.g., dogs and catsDog or cat bite is a common risk**Clinical presentation** Erythema , tenderness, and edema usually develop rapidly within 24 hRegional lymphadenopathy and fever may occurInfection that occurs days after the bite is usually caused by *S. aureus***Treatment** Clean wound with soap and waterTreatmentshould cover potential pathogens, e.g., *P. multocida, S. aureus*, and anaerobesAdministration of antibiotic within 8--12 h of injury may decrease the risk of infectionPenicillin is the drug of choice for *P. multocida* aloneAmoxicillin--clavulanate is the drug of choice for suspected polymicrobial wounds, including cat bitesClindamycin+ TMP-SMXis appropriatefor children allergic to penicillin

*Bordetella pertussis* {#Sec92}
----------------------

**Background** Small Gram-negative coccobacillus that infects only humansSpreads by aerosol droplets expelled while coughing or sneezing in proximity to othersIncubation period of7--10  days**Clinical presentation** Catarrhal phaseLasts from 1 to 2 weeksMild feverCoughThe cough worsensas the patient progresses to the paroxysmal phaseParoxysmal phaseLasts from 2 to 6 weeksRapid fire or staccato cough5 to 10uninterrupted coughs occur in succession, followed by a "whoop" as the patient rapidly draws in a breathMay occur several times per hourCan be associated with cyanosis, salivation, lacrimation, and post tussive emesisDespite the severe spells, patients often appear relatively well between episodesWhoop is usually absent in infants less than 6 months of ageGasping, gagging, and apnea can occurConvalescent phaseDecreasing frequency and severity of the coughing episodesLasts from weeks to months**Complications of pertussis** Pertussis is most severe in infants \< 6 monthsApneaPneumoniaSeizuresEncephalopathyDeath**Thoracic pressure-related complications** Pneumothorax or pneumomediastinumSubcutaneous emphysemaSuperficial petechial hemorrhageRib fractureRectal prolapseIntracranial hemorrhage**Diagnosis** PCR of NPspecimen collected with Dacron swab is diagnostic test of choicePCR remainspositive late in the course of the illnessLeukocytosis as high as 60,000 can be seen due to absolute lymphocytosis**Management** Infants afflicted with pertussis often require hospitalization for fluid, nutritional, and respiratory supportIf left untreated,most individuals will clear *B. pertussis* spontaneously from the nasopharynx within 2 to 4 weeks of infectionAntibiotics can shorten the course and attenuate the severity of pertussis if started early and can shorten the period of contagiousnessOnce the paroxysmal phase begins, antibiotics are not effective in altering the course of the diseaseExcluded from school for 21 days if untreated, or for 5 days while taking antibioticAzithromycinis the drug of choice:Infant less than 6 months: 10 mg/kg per day as a single dose for 5 daysOlder infants andchildren: 10 mg/kg as a singledose on day 1 then 5 mg/kg per day as a single dose on days 2--5**Prophylaxis to close contacts is the same as the treatment** Infants less than 1 yearPregnant womenImmunocompromisedUnderlying lung disease**Immunization** Because immunity to pertussis from the DTaP series wanes over time, a booster dose is recommended at age 11--12 years

Brucellosis {#Sec93}
-----------

**Background** Brucellosis is a zoonotic infection caused by the bacterial genus *Brucella*Brucellosiscaused by Gram-negative bacillusThe bacteria aretransmitted from animals to humans by ingestion of unpasteurized milk or cheese, direct contact with an infected animal, or inhalation of aerosols*B. melitensis* (from sheep; highest pathogenicity)*B. suis* (from pigs; high pathogenicity)*B. abortus* (from cattle; moderate pathogenicity)*B. canis* (from dogs; moderate pathogenicity)**Clues to** ***Brucella*** **infection** Fever of unknown originCulture negative endocarditisIndividuals at greatest risk for brucellosisare those exposed to goats, sheep, cows, camels, pigs, reindeer, rabbits, or hares, both in areas of endemic disease and in areas where the disease is not endemicBone/joint inflammationOrchitisHepatic abscessCNS symptoms**Diagnosis** Elevated liver enzymes is a common findingBlood culture (alert laboratory if suspecting *Brucella*, as lab staff easily infected)Serology is most commonly usedPCR in development**Treatment** Children \> 8: doxycycline+ rifampin for 6 weeksChildren \< 8:TMP/SMX + rifampin for 6 weeksAdd gentamicin for serious infection or complications

*Bartonella henselae* {#Sec94}
---------------------

### Cat-Scratch Disease {#Sec95}

**Background** *B. henselae* is Gram-negative rod or bacilli with a polar flagellumKittens or cats less than 1 year oldare most common source, also dogsTransmission can occur by petting alone with subsequent self-inoculation via a mucous membrane, skin break, or conjunctivaClue for the diagnosis: Contact with cats and lymphadenopathy**Clinical presentation** Regional lymphadenopathy (cervical and axillary are common locations) (Fig. [9.17](#Fig17){ref-type="fig"})Usually largeand may be tender, warm, and erythematousSuppuration can occur in 30% of casesNode may remain enlarged for several monthsPapule at the site of scratch may precede the development of lymphadenopathyParinaud oculoglandular syndrome:Painless nonpurulent conjunctivitisIpsilateral preauricular lymphadenopathyOther clinical presentationsFever of unknown originHepatic splenic microabscessesPainful osteolytic lesionsPatients may recall being scratched, licked, or bitten by a cat in the previous 2--8 weeksFever, anorexia, headache, sore throat, or arthralgia may occurLymphadenopathy remains regional and typically resolves within 2--4 months but may last up to 6--12 months**Diagnosis** Indirect fluorescence assay (IFA) testing and enzyme-linked immunoassay (ELISA) are used todetect serum antibody to *B. henselae*An antibody titerthat exceeds 1:64 suggests recent *Bartonella* infectionLymph node biopsygenerally is not indicated in typical cases**Treatment** Cat-scratch disease is self-limitedUse of azithromycincan decrease lymph node size faster than natural courseDoxycycline or rifampin may also treatImmunocompromised shouldreceive antibiotics**Surgical treatment** Remember : Incision and drainage are not recommended (risk of sinus tract and persistent drainage)Aspiration will bediagnostic and therapeutic; repeated aspirations may be performed if pus reaccumulates and pain recurs Fig. 9.1714-year-old female with large tender axillarylymphadenopathy, she has kittens at home

*Citrobacter* {#Sec96}
-------------

Cause brain abscess in neonatesOrder computed tomography (CT) or MRI if CSFgrowotherwise is very rare disease

*Klebsiella* {#Sec97}
------------

A rare cause of pneumonia and meningitisCan cause UTIs but isless common than *E. coli*Most are resistant to ampicillin

*Pseudomonas* Species {#Sec98}
---------------------

**Background** Gram-negative organismFound in the soil and freshwaterGains entrythrough hair follicles or via skin breaks**Risk factors** Cystic fibrosis (see Chap. 10.1007/978-3-030-21267-4_20 "Pulmonology")Associated with progressive deterioration of pulmonary functionAssociated with hot tub folliculitisOcular infection from contaminated lensesPuncture wound osteomyelitisIn immunocompromised patients, e.g., ecthyma gangrenosumHospitalized and debilitated patientsBurn woundsVentilator-associated pneumonia**Clinical presentation according to the site of infection** *Pseudomonas* keywordsNail- puncture wound through tennis shoesIV drugabuse, with endocarditis or osteomyelitisDiabetes with otitis mediaLeukemia with ecthyma gangrenosumHot tub folliculitisClinical presentation:The rash onset is usually 8 h to 5 days after exposure to contaminated waterErythematous pruritic macules that progress to papules and pustulesRash usually spares face, neck, soles, and palmsUsually confused with insect bites (history is important)Rash clearsspontaneously within 2--10 daysSelf-limited, require no antibioticsAcetic acid 5% compresses for 20 min twice a day for 4 days for symptomatic relief**Antimicrobial therapy** Piperacillin/tazobactam (Zosyn)Ceftazidime (third generation)Cefepime (fourth generation)Carbapenems (meropenem, imipenem)Aminoglycosides (gentamicin)AztreonamCertain fluoroquinolones (ciprofloxacin, levofloxacin)

Nontyphoidal Salmonellosis {#Sec99}
--------------------------

**Background** Gram-negative bacilli that are usually motile bacteriaA common cause of diarrheaIncubation period 6--72 h**Mode of transmission** Contaminated poultry, beef, eggs, fruits, vegetables, bakery, and dairy productsTurtles, iguana, and exotic reptiles**Clinical presentation** Can be asymptomaticMost commonpresentation is gastroenteritisAbrupt onsetof fever, nausea, and vomitingAbdominal crampsModerate-to-severe watery diarrhea most common manifestation**Diagnosis** Stool may show leukocytes, mucus, and bloodCBC; leukocytosis and shift to the leftAfter symptoms the patient can be a carrier for 4--5 weeks**Indication of antibiotic therapy** In infants less than 3 monthsInfant \< 12 months with temperature \> 39 °CHemoglobinopathies, e.g., sickle cell anemia, HIV, and neoplastic diseasesImmunocompromised patients at any age

Typhoid Fever {#Sec100}
-------------

**Background** *Salmonella enterica* serovar Typhi (*S.* Typhi)Mode of transmissionPoor sanitationand overcrowdingSpread by fecal--oral contamination of food or water by individuals who are carriers for *S.* Typhi in either stool or urineTyphoid is endemic in many developing areas**Clinical presentation** Fever "can exceed 104 °F (40 °C)"MalaiseChillsHeadache , anorexia, myalgias, and dry cough may be seenAbdominal pain is commonDiarrhea is more likely in childrenAbdominal tenderness, hepatosplenomegaly, and a coated tongueRose spots (pink, blanchable maculopapular lesions that are 2--4 mm in diameter) are seen on the torso and abdomenKnow: Neonatal typhoid generally presents within 3 days of birth with fever, emesis, diarrhea, abdominal distention,pronounced hepatomegaly, jaundice, and (sometimes) seizuresKnow: Absence of abdominal or intestinal changes is not typical of typhoid**Diagnosis** Blood cultures are the mainstay of diagnosis, positive in 50% of those with the diseaseStool culture mayincrease yield**Treatment** Treatment includes:Hydration and correction of fluid--electrolyte imbalanceAntipyretics andantibioticsThe choice of antibiotic, route, and duration depends on the host, site of infection, and sensitivities of the organismIV cefotaxime or ceftriaxone for 14 days is appropriateMultidrug resistant (MDR) strains, including resistance to ampicillin, TMP-SMX, cephalosporins, carbapenems, and fluoroquinolones have emerged mostly from Asia. Only azithromycinworks for these MDR strainsFor severe typhoid with obtundation, stupor, coma, or shock:Two-day course of IV dexamethasone may be life-saving

*Shigella* {#Sec101}
----------

**Background** *Shigella* is a Gram-negative bacillus*S. dysenteriae and S. flexneri* usually cause bloody diarrhea*S. sonnei and S. boydii* usually cause watery diarrheaIngestion of as few as 10 organisms can cause diarrheaIncubation periodis 2--4 daysOutbreak can occur in childcare centers**Mode of transmission** Person to personFecal-- oralAnal--oralHouse fliesContaminated fomites**Clinical presentation** Ranges from mild diarrhea to life-threatening dysenteryFeverAbdominal campsHigh-volume watery stoolsSmall-volume bloody stool may follow 24--48 h laterBlood-mucoid stool is a common presentationRectal prolapse occurs in 5--8%**Complications** Hemolytic- uremic syndromeSeizuresColonic perforationToxic encephalopathy**Diagnosis** Stool cultureis diagnosticStool study with large number of neutrophils is suggestive but not specificPeripheral WBCs are usually elevated; bandemia is very common**Treatment** Most infections with *S. sonnei* are self-limited and do not warrant antibioticsAntimicrobial therapy is recommended for immunocompromised patients with shigellosisAntimicrobial therapy for 5 days will shorten the duration and eradicate the organism from stoolAntimicrobial resistance testing guides therapyEmpiric ceftriaxone, ciprofloxacin or azithromycinare usually effectiveIf there is an alternative to ciprofloxacin, it is not recommended for those less than 18 years**Childcare center** Once *Shigella* is identified in a childcare center or household, all symptomatic individuals in these environments should be cultured for *Shigella*Anyone foundto have *Shigella* cannot return to the care center until the diarrhea has stopped and stool culture test is negative

*Escherichia coli* {#Sec102}
------------------

**Background** *E. coli* is a Gram-negative, lactose fermenting, motile rod, belonging to the *EnterobacteriaceaeE. coli* is one of the most frequent causes of many common bacterial infections, including cholecystitis, bacteremia, cholangitis, UTI, and traveler's diarrhea; and other clinical infections such as neonatal meningitis and pneumonia**Acute bacterial meningitis** The vast majority of neonatal meningitis cases are caused by *E. coli* and group B streptococcal infectionsPregnant women are at a higher risk of colonization with the K1 capsular antigen strain of *E. coli*, which is commonly observed in neonatal sepsisLow-birth weight and a positive CSF culture result portend a poor outcomeMost survivors have subsequent neurologic or developmental abnormalities**Pneumonia** *E. coli* respiratory tract infections areuncommon and are almost always associated with *E. coli* UTI**Intra-abdominal infections** *E. coli* intra-abdominal infections often result from a perforated viscus (e.g., appendix, diverticulum) or may be associated with intra-abdominal abscess, cholecystitis, and ascending cholangitisThey can be observed in the postoperative period after anastomotic disruption. Abscesses are often polymicrobial*E. coli* is oneof the more common Gram-negative bacilli observed together with anaerobes**Enteric infections** Enterotoxigenic *E. coli* (ETEC) is a cause of traveler's diarrhea; azithromycinis the drug of choice; infants \< 3 months can receive a third generation cephalosporinEnteropathogenic *E. coli* (EPEC) is a cause of childhood diarrhea; can be treated with TMP-SMX*Enteroinvasive E. coli* (EIEC) causes a *Shigella*-like dysenteryEnteroaggregative *E. coli* (EAEC) is primarily associated with persistent diarrhea in children in developing countries, and enteroadherent *E. coli* (EAEC) is a cause of childhood diarrhea and traveler's diarrhea in Mexico and North AfricaEnterohemorrhagic *E. coli* (EHEC) causes hemorrhagic colitis or hemolytic-uremic syndrome (HUS)Strains of STEC serotype O157:H7 have caused numerous outbreaks and sporadic cases of bloodydiarrhea andHUS**Urinary tract infections** The urinary tract is the most common site of *E. coli* infection, and more than 90% of alluncomplicated UTIs are caused by *E. coli* infectionThe recurrence rate after a first *E. coli* infection is 44% over 12 months*E. coli* UTIs are caused by uropathogenic strains of *E. coliE. coli* causes a wide range of UTIs, including uncomplicated urethritis, cystitis, pyelonephritis,and urosepsis**Other miscellaneous** ***E. coli*** **infections** Septic arthritisEndocarditisSoft tissue infections especially in patients with diabetes

*E. coli* (O157:H7) {#Sec103}
-------------------

**Background** Gram-negative rodsOccurs in all agesTransmitted via ingestion of contaminated food (e.g., ground beef) or infected fecesThe disease linked to eating undercooked beef and unpasteurized milk or apple juiceProduces Shiga toxins; the most virulent strainThe incidenceof *E. coli* O157:H7 \> *Shigella***Clinical presentation** Usually begins as nonbloody diarrhea then becomes bloodySevere abdominal pain is commonFever in one-third of the casesMay progress to hemorrhagic colitis in severe casesHUS may occur**Management** No antibiotic is proven effective, and antibiotic use may increase risk of HUSDo nottreat with antibiotics in most casesDo not use antimotility agents

*Yersinia enterocolitica* {#Sec104}
-------------------------

**Background** Small Gram-negative coccobacillusIt produces entero and endotoxinsPigs arecommonly infectedIngestion of raw or improperly prepared food, such as pork (pork intestine or chitterlings), contaminated unpasteurized milk, and water**Clinical presentation** Blood and mucus in stoolFeverRight lower quadrant painLeukocytosisMimics appendicitis**Treatment** No treatment for isolated intestinal infectionIf \< 6 months old, extraintestinal manifestation, sepsis, or immunocompromised, then antibioticis indicatedCefotaxime or ceftriaxone

*Francisella tularensis* {#Sec105}
------------------------

**Background** Gram-negative pleomorphic bacillus that causes tularemia or "rabbit fever"Found in many animals, especially rabbitsTransmitted by ticks and blood-sucking fliesOrganism can be ingested or inhaledPrevalent in the Southwest desert; Arkansas, Missouri, and Oklahoma**Clinical presentation** Fever, chills, myalgias, and arthralgiasIrregular ulcers at the site of inoculationLymphadenopathy that suppurates and forms an ulcerOculoglandular tularemia (unilateral conjunctivitis, corneal ulceration)Pneumonic tularemia (dry cough, dyspnea, and pleuritic-type chest pain)Typhoidal tularemia (fever, chills, myalgias, malaise, and weight loss)**Diagnosis** Serology, e.g., ELISA or PCR**Treatment** Gentamicin or streptomycinfor 10 days**Prevention** Avoid tick-infested areas, check clothing for ticks, and use tick repellentsAvoid exposure to dead orwild mammals and wear gloves if such exposure is necessary; hands should be thoroughly washed afterward

Rocky Mountain Spotted Fever (RMSF) {#Sec106}
-----------------------------------

**Background and epidemiology** Tickborne rickettsial diseaseTransmitted bythe American dog tick (*Dermacentor variabilis*) east of the Rocky Mountains and Pacific coastSpread by Rocky Mountain wood tick (*D. andersoni*) in Rocky Mountain regionSpread by Brown dog tick (*Rhipicephalus sanguineus*) worldwideCaused *by*Peak transmissionin summer**Clinical features** Early illness (days 1--4)FeverMalaiseHeadacheAbdominal painMyalgiasRash appears 2--4 days after fever; 10--15% do not have rashMaculopapular rash starts at the wrists and ankles, spreads centrally to palms and solesRash becomes petechial and purpuricLate illnessAltered mental statusPulmonary edema, acute respiratory distress syndrome (ARDS)Multiorgan failure(CNS, kidney)**Laboratory** Serology testing: Indirect fluorescent antibody (IFA) for IgG at presentation and 2--4 weeks later. Frequently negative during 1st week of illnessPCR blood may be helpful if positive but does not rule out infection, as the organism is intracellular**Treatment** Start treatment before testing results return; can be fatal within daysDoxycyclineis the treatment of choice even in children \< 8 yearsAntibiotic is given for at least 5--7 days and at least 3 days after fever resolvesBest outcome when treatment started within 5 days of illness**Complications** VasculitisDisseminated intravascular coagulation (DIC)Death

Ehrlichiosis {#Sec107}
------------

**Background and epidemiology** Gram-negative cocciTransmitted by:Lone star tick (*Amblyomma americanum*) in South Central and Eastern United States. Also transmits for tularemia and southern tickassociated rash illness (STARI)Blacklegged tick (*Ixodes scapularis*) in Eastern United States. Also transmits for anaplasmosis, Lyme disease, and babesiosisCan transmit via blood transfusion and organ transplantationPeak transmission in summerIncubation period is 5--14 days**Clinical presentation** Similar to RMSF with early and late illness (Table [9.2](#Tab2){ref-type="table"})Maculopapular rash sparing the face that may spread to palms/soles; appears in 60% of children 5 days after fever begins**Laboratory findings** LeukopeniaNeutropeniaThrombocytopeniaHyponatremiaElevated liver enzymes**Treatment** Drug of choice isdoxycycline, including children \< 8 years Table 9.2Difference between Rocky Mountain spotted fever and ehrlichiosisDifferenceRocky Mountain spotted feverEhrlichiosisMode of transmissionTickTickRashVery common, including on palms and soles60% of childrenNeutropeniaLess commonMore commonThrombocytopeniaYesYesAnemiaPresent in \~15%Occurs in 50% later in illnessHyponatremiaYesYesLiver enzymesMay be elevatedUsually elevatedTreatmentDoxycyclineDoxycycline

*Borrelia burgdorferi* {#Sec108}
----------------------

**Lyme DiseaseBackground** Tick-borne infection caused by spirochete *B. burgdorferi*Transmitted by*Ixodes* species ticks in the nymphal stageCommonly seen in spring and summerCommon regions in the USA: Northeast to Mid-Atlantic (\> 90%), upper Midwest (Wisconsin and Minnesota), West Coast (California)Incubation period: 11 days**Early localized disease stage I** Erythema migrans (pathognomonic skin lesion) either bullseye or clear centerMyalgiaArthralgiaMild fever**Early disseminated disease stage II (weeks to months later)** Multiple erythema migrans lesionsMeningitis (lymphocytic)Cranial nerve palsies, e.g., Bell palsyPeripheral neuropathy, e.g., foot dropHeart block: first, second, or third degree**Late disseminated disease stage III** ArthritisOligo- migratory arthritisRemember: Lyme disease can be confused with juvenile idiopathic arthritis (JIA)**Diagnosis** Erythema migrans is pathognomonic and is an early lesion; antibodies not developed yetNo need to test. Treat based on clinical diagnosisSerologic testingindicated to confirm early and late disseminated disease. Two-tiered testing:Initial test is highly sensitive enzyme immunoassay assay (EIA). If positive, thenWestern blot test, considered positive if *either*2 IgM bands positive, *or*5 IgG bands positive**Treatment** Early localized: Doxycyclinefor 10 days (amoxicillin for 14 days if \< 8 years)Isolated facialpalsy: Doxycyclinefor 14 daysAV block or meningitis: Doxycyclineor ceftriaxone for 14 daysArthritis: Doxycyclinefor 28 days (amoxicillin for 28 days if \< 8 years)

*Treponema pallidum* {#Sec109}
--------------------

**Background** *T. pallidum* is spirochete mobile bacteriaMode of transmission:Sexual contactTransplacental (congenital)Exposure to infected blood or tissue**Clinical presentation** Congenital syphilis Stillbirth, hydrops, preterm, or asymptomaticHepatosplenomegalySnuffles (nasal secretions)LymphadenopathyMucocutaneous lesionsPneumoniaBone findings: Osteochondritis and periostitisMaculopapular rash prominent on hands and feet that are highly infectiveLate manifestations: Interstitial keratitis, deafness, Hutchinson teeth (peg-shaped incisors), anterior bowing of shins, frontal bossing, mulberry molars, saddle nosePrimary syphilis Genital chancre 3 weeks after exposurePainless papule that then become painless ulcer, which is very contagiousSecondary syphilis 2--10 weeks after the chancre healsMaculopapular rash involving palms and soles*Condyloma lata* (wart-like plaques around the anus or the vagina confused with *condyloma acuminata* seen in HPV)Generalized lymphadenopathyTertiary syphilis (symptomatic late syphilis 15--30 years after initial infection)Cardiovascular, CNS, gummatous lesions**Diagnosis and treatment** Screening methods:Rapid plasma reagin (RPR) and venereal disease research laboratory (VDRL) test correlatewith disease activityOther infections and autoimmune diseases can cause false positive RPR or VDRLFluorescent treponemal antibody absorption (FTA-ABS) test confirms the diagnosis, and this test remains positive for lifeCongenital syphilis:Unlikely: No evaluation or treatment. Maternal titer low/negative and history of adequate treatment, normal infant physical exam, and infant titer \< 4-fold the maternal titerLess likely: Benzathine penicillin G single dose, no evaluation. Maternal history of adequate treatment \> 4 weeks before delivery, normal infant physical exam, and infant titer \< 4-fold the maternal titerPossible: Aqueous crystalline penicillin G for 10 days; analysis of CSF, CBC, long bone radiographs: Mother not treated adequately or treated \< 4 weeks before delivery, normal infant physical exam, and infant titer \< 4-fold the maternal titerProven/highly probable: Aqueous crystalline penicillin G for 10 days; analysis of CSF, CBC, chest and long bone radiographs; transaminase; neuroimaging; ophthalmologic exam. Mother not treated adequately or treated \< 4 weeks before delivery, or abnormal infant physical exam, or infant titer 4-fold higher than maternal titerTreatment withpenicillin for acquired syphilis, with doxycyclineor tetracycline if allergic to penicillin

*Mycobacterium tuberculosis* {#Sec110}
----------------------------

**Background** *M*. t*uberculosis*, atubercle bacillus, is the causative agent of tuberculosis (TB)Mycobacteria, such as *M. tuberculosis,* are aerobic, non-spore-forming, non-motile, facultative, curved intracellular rods measuring 0.2--0.5 μm by 2--4 μmRetains many stains after decolorization with acid-alcohol, which is the basis of the acid-fast stains used for pathologic identificationTB spreads most commonly via airborne transmissionTB is unlikely to spread from child \< 4 years of age due to limited tussive forceTB is likely to spread from infected adults to children (usually household or childcare center)**Risk factors** Foreign-born individuals in the USA have TB rates 9.5 times higher than those of persons born in the USAHIV infection,treatment with TNF-alpha antagonists such as infliximab and etanercept, and other immunocompromising conditionsRecent latent tuberculosis infection (LTBI)IV drug useCertain medical conditions such as diabetes and renal failureIncubation period from exposure to positive test is 2--10 weeks**Clinical presentation** Only 5--10% of children older than 3 years of age who have untreated LTBIprogress to diseaseMost LTBIprogress to disease within 1--2 years of initial infectionThe most common site of infection is the lung (up to 80%)**Pulmonary disease** Infants and adolescents are more likely to be symptomatic than 5 to 10-year-old childrenCough (usually last 3 weeks or longer)HemoptysisLow-grade feverWeight loss (rare)Night sweatsLoss of appetiteHilar or mediastinal adenopathy may be seenCavity lesions**Superficial lymphadenopathy** The most common extrapulmonary form of TBChildren who have TB lymphadenopathy tend to be older than those who have nontuberculous mycobacterial lymphadenopathyCommon locations: Anterior cervical, followed by posterior triangle, submandibular, and supraclavicularLymph nodes usually measure 2--4 cm and lack the classic inflammatory findings of pyogenic nodesThere may be overlying violaceous skin discolorationSurgical node excision is not curative but may be necessary to establish the diagnosisMost children respond well to a 6-month course of multidrug therapy, but occasionally therapy mustbe extended to 9 months, based on clinical response**CNS disease** Tuberculomas, occurring in 5% of children who have CNS TB, appear as single rim-enhancing lesions ranging from 1 to 5 cmIn TB meningitis, CSF analysis typically demonstrates lymphocytes, a low-glucose concentration, and a high-protein valueThe most common findings on CNS imaging:Hydrocephalus and basilar enhancementVascular lesions involving the basal ganglia and midbrain also are commonTB should be considered incases of childhood stroke**Pleural TB** Seen more in older child and adolescentCan occur inisolation or concomitantly with pulmonary parenchymal diseaseSymptoms include chest pain, fever, cough, dyspnea, and anorexia. Auscultatory findings mimic those of bacterial pneumoniaMost children have positive tuberculin skin test (TST) resultsEffusions are more common on the right and rarely bilateralThe pleural fluid is exudative and lymphocyticA 6-month course oftherapy is recommended**Miliary tuberculosis** Due tolymphohematogenous spread, it is a disease of the young or immunocompromised childrenMiliary disease can present shortly after primary infectionMultiorgan involvement is commonClinical presentation:PyrexiaHepatomegaly and splenomegalyTST is insensitive because disseminated disease can produce TST anergyAFB culture from gastric aspirates can have a yield as high as 50%A prolonged course of therapy (9--12 months) should be administered to patients who havedisseminated disease**Skeletal TB** The mostcommon manifestations of skeletal disease are:SpondylitisArthritisOsteomyelitisMost patients are in the second decade of lifeSpinal involvement (Pott disease), which can affect even young childrenSkeletal lesions can develop more than 10 years after initial infectionMRI is the preferred imaging choice because it can demonstrate lesions months before plain radiographsChest radiographs are positive in 50% of children who have skeletal TBTST results are usually positive**Other forms of TB include:** AbdominalRenalCutaneous disease**TB testing** Cultures can be obtained by sequential sputum sampling or by gastric aspiration of early morning secretions in the younger childThe bacillus grows slowly6 to 8 weeks to grow on Lowenstein--Jensen media2 to 3 weeks to grow in liquid mediaAFB stains include Kinyoun, auramine--rhodamine (Truant), and Ziehl--NeelsenTuberculin skin test (TST) (Table [9.3](#Tab3){ref-type="table"})Measured in millimeters of induration (not erythema)Reading is 48--72 h after placementPreferred for children \< 2 yearsKnow: If a child returns for TST interpretation after 72 h and has induration meeting the criteria for positivity, the test is considered positive.A negative result never eliminates the possibility of TB disease because many disseminated forms of TB, including TB meningitis, can induce TST anergyFalse-negative TST results:Recent measles infection or vaccinationHigh-dose corticosteroid treatment, irradiationImmunosuppressive therapyImmunocompromising medical conditionsDisseminated tuberculosisFalse-positive TST result:Primarily in children exposed to nontuberculous (environmental) mycobacteriaChildren recently received a bacillus Calmette--Guérin vaccineA boosting phenomenon: Children received multiple sequential TSTsFirst screen for exposure risk by history before testing. Do not test all children routinelyBacillus Calmette--Guérin (BCG) vaccineTST can be interpreted normally in a child who received a single dose of BCG vaccine as a young childHaving received BCG as an infant may not explain a positive skin test result later in lifeThe assumption thatBCG receipt is the cause of a positive TST could lead to a lack of treatment for high-risk children who potentially could benefit from LTBItherapyWhole blood interferon-gamma release assays (IGRAs) have several potential advantages:Only one office visit is requiredThere isno risk of the boosting phenomenonMore specificity for LTBIbecause the antigens in the IGRAs is shared less commonly with nontuberculous mycobacteria and are not found on BCGChest radiographsChildren who have LTBIusually have normal-appearing chest radiographsAn isolated calcified lesion in a child who has a positive TST result can be treated as LTBIThe most common abnormal radiographic finding is hilar or mediastinal adenopathyOther findings caninclude infiltrates, atelectasis, pleural effusions, cavities, or miliary diseaseTB exposure:Children younger than 4 years of age and immunocompromised childrenShould begin isoniazid (INH), pending results of repeat testingIf the second test result is negative, medication can be discontinuedChildren experiencing TB exposure who are older than age 4 years and immunocompetent can be observed off medications, pending the second test result in 2--3 months**Latent TB infection (LTBI** **)** The childdemonstrating a positive skin test result should be treated for LTBIto decrease the risk of disease progression later in lifeThe mainstay of therapy for LTBIis 12 weeks of daily INH and weekly rifampinAn alternative is 4 months of daily rifampin (for INH intolerant or resistance)**Treatment of TB** The standard initialregimen for pulmonary and extrapulmonary TB:INH, rifampin, pyrazinamide (PZA), and ethambutolINH and rifampin are administered for 6 months, and PZA and ethambutol are stopped after the first 2 monthsExceptions: Treating children who have TB meningitis, where treatment courses of 7--12 months often are used**Side effects of antituberculous medications** INH, rifampin, and PZA are all hepatotoxicEthambutol can rarely cause optic neuritis (decreased color perception is the first sign of deterioration)Pyridoxine supplementation indicated for exclusively breastfed infants, nutritional deficiencies,symptomatic HIV, and pregnant females**Challenging clinical scenarios** Adult in the household has infectious TBAll children in the household should have chest radiographs and TSTs performedChildren younger than 4 years of age should be started empirically on INH and rifampin until the TST is repeated in 2--3 monthsIf the second TST result is negative and the child is immunocompetent, medication can be discontinuedIf the TST result is positive or the child is immunocompromised, INH and rifampin should be continuedInfant whose mother has TBThe TST is helpful only if the result is positive, which is very rareIf the mother has a positive TST result and negative chest radiograph (LTBI ), the child needs no evaluationIf the mother hasradiographic features consistent with TB, the neonate requires evaluation for congenital TBIf the infant does not have congenital TB, he or she should be separated from the mother until the infant is receiving INH and pyridoxine (if the mother is breastfeeding) and the mother is receiving appropriate multidrug therapyOnce the infant is receiving INH, separation is unnecessary, and breastfeeding should be encouraged unless INH resistance is suspectedHealth-care workers (HCWs)If positive TST results, they should receive chest radiographsIf the chest radiograph is negative, the HCW may be offered therapy for LTBIafter weighing the risks and benefits of latent TB treatment in adultsIf the chest radiograph is positive, the HCW needs to be evaluated further**Follow-up** Children who have TB disease should be seen monthly while receiving therapy to document medication tolerance and adherence, weight gain, and achievement of appropriate milestones Table 9.3Positive tuberculin test reaction results in infants, children, and adolescentsInduration of 5 mm or moreInduration 10 mm or moreInduration more than 15 mmChildren in close contact with known or suspected contagious people with tuberculosisChildren \< 4 years of ageChildren 4 years of age or older without any riskChildren with suspected tuberculosis either clinically or on chest radiographChildren with other medical conditions, including Hodgkin disease, lymphoma, diabetes, renal failure, malnutritionChildren receiving immunosuppressive therapy or with immunosuppressive conditions, including HIVChildren born in, or who travel to, high-prevalence countriesChildren exposed to adults in high-risk categories

Mycobacterium Avium-Intracellulare {#Sec111}
----------------------------------

**Background** Mycobacterium avium-intracellulare complex is the most common cause of nontuberculousdisease in childrenCaused by two types of bacteria:*Mycobacterium avium* and *Mycobacterium intracellulare*Usually occurs in children with impaired cell immunity, including very young children \< 5 years oldOrganisms are ubiquitous in soil**Clinical presentation** Cervical lymphadenitisOverlying skin is usually pink to violaceousUsually unilateralIncrease in size over several weeksCutaneous infectionsEar infectionsDisseminated and pulmonary infections (high fever, night sweats, weight loss, lymphadenopathy, abdominal pain, diarrhea, and anemia) can occur in immunocompromised**Management** Complete resection of infected lymph node is diagnostic and curative. Antibiotics are not necessary!Azithromycinor clarithromycin in combination with ethambutol or rifampin if cannot be resected

Fungal Infections {#Sec112}
=================

*Candida* Species {#Sec113}
-----------------

*Candida albicans* is the most commonly isolated species, and causes infections (Candidiasis or thrush)Systemic infections of the blood streamand major organs (invasive candidiasis or candidemia, particularly in immunocompromised patients)*Candida* appears as budding yeast cells and pseudohyphae (Fig. [9.18](#Fig18){ref-type="fig"}) Fig. 9.18in blood culture (Gram stain, original magnification × 1000). Budding yeast cells (blastoconidia, *black arrow*) and pseudohyphae (*white arrow*). (Courtesy of M. Nawar Hakim, MD, Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA)

Oral Thrush {#Sec114}
-----------

**Background** Common in the first 6 postnatal monthsPossibly due to infants' immunologic immaturity**Infection sources** Contaminated bottle nipples, pacifier, or dropper, e.g., vitamin dropperInfected mother's nipples (although the incidence is high in formula fed infants)Maternal vaginalcolonization with *Candida***Recognize** Recurrent or persistent oral thrush beyond 6--12 months raises the concern of immunodeficiency, especially if associated withfailure to thrive or hepatosplenomegaly**Risk of infection** Use of inhaled steroid without adequate rinsing afterward or oral antibiotics can cause oral thrushPoorly controlleddiabetes in adults can cause *Candida* infection; however, it is not associated with gestational diabetes**Clinical presentation** Infants may have trouble feeding in severe casesTiny focalwhite area that enlarge to white patches on oral mucosa (Fig. [9.19](#Fig19){ref-type="fig"})If scraped with a tongue blade, lesions are difficult to remove and leave behind an inflamed base that may be painful and may bleedExamine the patient with diaper dermatitis for oral lesions**Treatment** Oral nystatinOnce-daily oral fluconazole is superior to oral nystatin for resistant thrush Fig. 9.19Thrush : Tiny focal white areas that enlarge to white patches on oral mucosa; it was difficult to remove the white spots with the tongue blade

Candidal Diaper Dermatitis {#Sec115}
--------------------------

**Clinical presentation** Lesions consist of beefy-red plaques, often with scalloped bordersSatellite papulesand pustules may be observed surrounding the plaques (Fig. [9.20](#Fig20){ref-type="fig"})Maceration is often present, especially in intertriginous areas**Treatment** Topical nystatin, miconazole,clotrimazole Fig. 9.20Candidal diaper rash: Lesions consist of beefy-red plaques with satellite papules

Vulvovaginitis {#Sec116}
--------------

**Background** Common in pubertal and adolescent girlsRisk factorsOral antibioticsOral contraceptivePregnancyPoor hygieneDiabetes**Clinical presentation** Vulvar/vaginal erythema and itchingWhite, cottagecheese-like vaginal discharge**Treatment** Topical nystatinor clotrimazoleSingle dose oforal fluconazole for recurrent or refractory cases

Candidal Infections in Neonates {#Sec117}
-------------------------------

**Background** Very low-birth-weight and premature infantsCentral line-associated bloodstream infection (CLABSI): Obtain blood culture from periphery and catheter**Treatment** Remove the catheter if CLABSIParenteral micafungin or amphotericin, pending identification and sensitivity testing

*Aspergillus* {#Sec118}
-------------

**Background** *Aspergillus* speciesconsist of ubiquitous molds found in organic matterMost common species affecting humans are *A. fumigatus* and *A. niger***Mode of transmission** Inhalation of fungus sporesOutbreaks can occur during hospital construction**Clinical presentation** Invasive aspergillosis: Immunocompromised (neutropenia, graft-versus-host disease)Pulmonary, sinus, skin, intracranialInvasion of vasculature with erosion and hemorrhageAspergillomas and otomycosis: Colonization in immunocompetent childrenGrowth in cavities or cysts without invasionUnderlying cystic fibrosis and TBAllergic bronchopulmonary aspergillosis: HypersensitivityWheezing, mucous plugging, fever, eosinophilia, transient lung infiltratesUnderlying asthma or cystic fibrosisAllergic sinusitisNasal polyps or sinus surgeryDark nasaldischarge**Diagnosis** Branched and septate hyphae seen on tissueor BALMolecular testing is definitiveGalactomannan assay from BAL specimen and serum**Treatment** Invasive aspergillosis: VoriconazoleAllergic bronchopulmonary aspergillosis: Corticosteroids

*Malassezia furfur* {#Sec119}
-------------------

**Overview** Can cause tinea versicolor (see Chap. 10.1007/978-3-030-21267-4_26 "Dermatology")Can causeneonatal infection in NICU babies receiving total parenteral nutrition (TPN) with lipidsNICU babies with *M. furfur* may present with fever, bilateral interstitial infiltrates, and increased WBCs*M. furfur* requires olive oil overlay to grow**Management of infection in neonates** Removal of cathetersStop lipid infusionStart amphotericin B or fluconazole

Histoplasmosis {#Sec120}
--------------

**Background** Endemic areas: Ohio, Missouri, and Mississippi River valleysMode of transmissionInhalation of spores from bird excreta or contaminated soilNo person-to-person transmission**Clinical presentation** Flu-like symptomsPulmonary infiltratesHilar lymphadenopathy with or without calcificationsErythema nodosumIn younger children maydevelop progressive disseminated histoplasmosis**Treatment** Not indicated for immunocompetent children with mild/moderate diseaseSevere or disseminated infection, especially in immunocompromised, treated with amphotericinB + steroids

*Coccidioides* {#Sec121}
--------------

Coccidioidomycosis {#Sec122}
------------------

**Background** Endemic areasCalifornia, Arizona, New Mexico, and TexasMode of transmissionInhalation of airborne spores**Clinical presentation** Most cases are asymptomaticFeverCoughWeight loss (common)FatigueShortness of breathChillsErythema nodosumNight sweatsMild respiratory distress or respiratory failure in severe cases**Diagnosis** Serology: The appearance of IgM or precipitin antibody against *Coccidioide*s is the most sensitive serologic indication of early infectionCulture and DNA probe is the most definitive method for the diagnosisHigh index of suspicion is important in patient who travelled or underlying medical conditionsElevated erythrocyte sedimentation rate (ESR)Lymphocytosis and monocytosisEosinophilia \> 5%Chest radiograph may show consolidations and hilar lymphadenopathy**Treatment** Not indicated for immunocompetent children with mild/moderate diseaseSevere or disseminated infection, especially in immunocompromised, treated with fluconazole or itraconazoleHigh dose fluconazole for CNS infections*Blastomyces* *Blastomyce*s causes illness similar to *Histoplasma* and *Coccidioides*Seen in Arkansas and Wisconsin hunters and loggersOutbreak occurred in children visiting Wisconsin lodge and beaver damB*lastomyces* may disseminate to the skin and cause crusted skin lesionsBone lesions more common with blastomycosisItraconazole (mild disease) or amphotericin B (severe disease) are thetreatments of choice*Sporothrix schenckii* Common in florists, as thorny plants are implicatedSymptoms appear from 7 to 30 days after inoculationPresent with painless papule at the site of inoculation, then ulceratesSecondary lesions follow along the lymphatic chain proximallyExtracutaneous manifestation may occur, especially in immunocompromisedTreat with itraconazole for 2--4 weeks

Protozoa {#Sec123}
========

*Giardia lamblia* {#Sec124}
-----------------

**GiardiasisBackground** Giardiasis isan infection of the small intestine caused by the flagellated protozoan *Giardia intestinalis*Mode of transmissionTravelers and hikers who drink water contaminated with stool from infected animals such as beavers, muskrats, and sheepOutbreaks also may occur from sewage contamination of water suppliesUnprotected anal sex also is a source of transmissionChildcare centers from fecal--oral transmissionFood-associated outbreaks may occur**Clinical presentation** Most infections remain asymptomaticWatery diarrhea with abdominal crampingNauseaVomitingWeight lossFlatulence**Diagnosed** Microscopic examination of the stool for cysts or byantigen detection**Treatment** Indicated for all symptomatic patientsMetronidazole, a single dose of tinidazole, or nitazoxanide for 3 daysImmunocompromised patients at increased risk for chronic giardiasisand treatment failure

*Entamoeba histolytica* {#Sec125}
-----------------------

**Background** Amebiasis is caused by pathogenic species of EntamoebaMode of transmissionFecal--oral routeTravel to high-risk areas with poor sanitation and hygiene**Clinical presentation** Can be asymptomaticAmebic dysentery or colitisBloody diarrhea with mucusTenesmusHepatic abscessFeverAbdominal painTender enlarged liverElevated liver enzymesElevated ESR**Diagnosis** Serum antibody (95% detectable in invasive amebiasis)Stool microscopic examinationStool antigenUltrasound if liver abscess is suspected**Treatment** Symptomatic cases with systemic symptomsMetronidazole followed by paromomycin or iodoquinol to eradicate colonizationAsymptomatic amebiasis in nonendemic areas should be treated with a luminal agent (iodoquinol, paromomycin, or diloxanide furoate) to eradicate infectionAmebic liver abscesscured by medical therapy without drainage

Cryptosporidiosis {#Sec126}
-----------------

**Background** Cryptosporidiosis, causedbyTransmitted via fecal--oral route; childcare centers and swimming pools**Clinical presentation** Nonbloody, watery diarrheaChronic diarrhea in immunodeficient patientsTest usingDFA in stool; routine ova and parasite testing insufficient**Treatment** Many immunocompetent patients who have cryptosporidiosis have self-limited disease and do not require therapyA 3-day course of nitazoxanide:To reduce durationand transmission of diarrhea in children older than 1 year of ageNo swimming pool for at least 2  weeks after diarrhea ends

*Toxoplasma gondii* {#Sec127}
-------------------

**ToxoplasmosisBackground** Obligate intracellular protozoaMode of transmissionIngestion of contaminated raw or uncooked meatCat excretaOrgan transplantsTransplacental to fetus causes congenital toxoplasmosis (see Chap. 10.1007/978-3-030-21267-4_2 "Neonatology")**Clinical presentation** Most cases are asymptomaticFeverMalaiseRashMyalgiaCervical lymphadenopathy (most common sign)Brain abscess (test for HIV)Chorioretinitis usually present years later (mostly congenital)**Diagnosis** Head CT:Ring-enhanced lesion, intracerebral calcificationsToxoplasma IgM antibodiesPCR**Treatment** Infants with congenital toxoplasmosis: Pyrimethamine plus sulfadiazine and folic acidPregnant females: Spiramycin

*Pneumocystis jiroveci* {#Sec128}
-----------------------

**Pneumocystis PneumoniaBackground** Unicellular fungi that do not respond to antifungal treatmentMode of transmission is unknownCommonly seen in immunocompromised patients, e.g., HIV patients**Clinical presentation** Subacute diffuse pneumonitisDyspneaTachycardiaHypoxemia that is exaggerated with exertionNonproductive coughFever**Diagnosis** Chest radiographyBilateral diffuse interstitial diseaseLow CD4BALLung biopsy**Treatment** TMP-SMXIV pentamidinein severe casesProphylaxis inimmunocompromised patientsTMP- SMX

*Plasmodium* {#Sec129}
------------

**MalariaBackground** Intracellular protozoaTransmitted by mosquito bites in endemic areas of the tropics*Plasmodium falciparum* Most severe,causing death within 48 h if untreatedSymptoms develop 10 days after mosquito bite, longer if taking prophylaxisComplicationsCerebral malariaPulmonary edemaSevere anemiaRenal failureShockTreatmentChloroquine sensitive (rare)ChloroquineChloroquine resistantArtemether--lumefantrineQuinine plus doxycyclineor clindamycinAtovaquone--proguanilSevere casesIV artesunate (available from Centers for Disease Control and Prevention \[CDC\] only; not yet FDA-approved)Quinidine gluconate IV (no longer produced for the US market as of 2019) plus doxycyclineor clindamycin***P. malariae, P. vivax, and P. ovale*** Periodicity of symptomsNephrotic syndrome -- *P. malariae* (most benign form)Hypersplenism andsplenic rupture -- *P. vivax* and *P. ovale*TreatmentChloroquine plus primaquine for *P. vivax,* and *P. ovale*Chloroquine for *P. malariae***Clinical presentation of malaria** History of traveling to endemic areaParoxysmal fever, sweat, and rigorsPallor and jaundiceHeadache andmyalgiaAbdominal painVomiting and diarrheaIn severe casesAltered mental statusHepatosplenomegalyAnemiaThrombocytopeniaHypotensionHypoglycemiaHyperkalemiaRespiratory distress**Diagnosis** Rapid diagnostictest (immunochromatographic test)Thick blood smearPCR available, butresults are delayed**Prevention** Traveling tochloroquine resistant areas, e.g., most tropical areas with malariaAtovaquone--proguanil 1--2 days before and 7 days after travel, *or*Doxycycline(\> 8 years old) 1 week before until 4 weeks after travelTraveling to chloroquinesensitive areas, e.g., Central AmericaChloroquine 1--2 weeks before and 4 weeks after, *or*Atovaquone--proguanil 1--2 days before and 7 days after travel

Helminthic Organism {#Sec130}
===================

*Enterobius vermicularis* {#Sec131}
-------------------------

**PinwormMode of transmission** Person-to- person via fecal--oral routeEggs survive upto 3 weeks and are ingested fromfinger nails, bedding, and toysAutoinfection**Clinical presentation** Anal andvulvar itching (more at night)Enuresis**Diagnosis** Visualizing the adult worm at night on the perineumTransparent tape collected over three consecutive mornings under microscope low power**Treatment** Pyrantel pamoate (over-the-counter ), albendazole, mebendazole

*Ascaris lumbricoides* {#Sec132}
----------------------

**AscariasisMode of transmission** Ingestion of eggs from contaminated soil (fecal--oral)**Clinical presentation** Most patients are asymptomaticNonspecific abdominal pain or discomfortIntestinal obstruction (large number of worms)Due to larvae migration to the liver and lung:Obstructive jaundicePeritonitisCough (Loeffler syndrome)**Diagnosis** Seeing the ova on microscopic stool examinationSeeing theadult worm itself**Treatment** Pyrantel pamoate (over-the-counter),albendazole, mebendazole

*Necator americanus* {#Sec133}
--------------------

### *Ancylostoma duodenale* {#Sec134}

**HookwormBackground** Found inrural, tropical, and subtropical localesMode of transmissionSkin penetration of larvae from soil contaminated by humanfecesIngestion**Clinical presentation (blood sucker worms from the intestine)** Itchiness and burning sensationPharyngitis and gastroenteritisFailure to thriveShort statureAnemia due tochronic blood loss**Diagnosis** Visualization of eggs in stool (may take 5--10 weeks after infection)**Treatment** Pyrantel pamoate (over-the-counter), albendazole, mebendazole

Trichuriasis {#Sec135}
------------

**Whipworm** Due toinfection of large intestine withMore common in the Southern United StatesTransmitted to humans by ingesting eggsUsually asymptomatic if only few wormsCan cause fever, abdominal pain,weight loss, blood in stool, and rectal prolapsePresence of eggs in stool is diagnosticTreatment iswith albendazole, mebendazole, or ivermectin

*Trichinella spiralis* {#Sec136}
----------------------

**Trichinellosis** *T. spiralis* is usually found in porkSymptoms depend on the worm locationAfter ingestion the eggs hatch, larvae invade the duodenum and cause abdominal symptomsLarvae penetrate, reach bloodstream, end in muscular tissue and cause muscle painIf the larvae reach the heart, can cause myocarditisOcular involvement: Presence of chemosis, periorbital edema, and eosinophilia usually suggest the diagnosisDiagnosis is confirmed by rising titersTreatment iswith albendazole ormebendazole

*Strongyloides stercoralis* {#Sec137}
---------------------------

**Strongyloidiasis** *S. stercoralis* is common in certain areas (Kentucky and Tennessee) of the USAThe only helminthic organism that replicates in the body with autoinfection, and the infection may persist for decadesCan cause pulmonarysymptoms with eosinophilia and GI symptomsPotentially fatal in immunosuppressed patientsDiagnosis of serial stool studies for larvae not the eggsTreatment : Ivermectin or albendazole

Toxocariasis {#Sec138}
------------

and can cause visceral larva migransTransmitted to humans by ingesting soil contaminated with dog or cat excretaIn humans larvae do not develop into adult worms but rather migrate through the host tissue, causing eosinophiliaTreatment: Albendazole or mebendazole

Cestodes (Platyhelminthes) {#Sec139}
--------------------------

Platyhelminthes include cestodes (tapeworms) and trematodes (flukes)Cestodes are flatworms (tapeworms)The pork tapeworm , present in two different waysIf the cysticerci are ingested, taeniasis develops and tape worm grows in the intestineIf contaminated food with eggs is ingested, the patient will develop cysticercosisCysticerci live in CNS and the eyes and do nothing until they dieDiagnosis of neurocysticercosis must be considered in patients with new onset seizures and history of traveling to or immigration from Mexico, Central, or South America, or who are from a household in these areasTreatment : Albendazole or praziquantel

Trematodes (Platyhelminthes) {#Sec140}
----------------------------

Trematodes or flukesis the Chinese liver flukeinfects the bladder and causes urinary symptomsis a fluke found in Africa, the Middle East, and South Americais found in AsiaMost serious complications of Schistosomiasis is cirrhosis with esophageal varicesTreatment: Praziquantel

Fever {#Sec141}
=====

Fever Without Focus {#Sec142}
-------------------

### Febrile Neonate {#Sec143}

**Background** Difficult to distinguish between a serious bacterial infection and self-limited viral illness in this age groupNeonates who havefever and do not appear ill have a 7% risk of having a serious bacterial infectionSerious bacterial infections include occult bacteremia, meningitis, pneumonia, osteomyelitis, septic arthritis, enteritis, and UTILate onset neonatal bacterial diseases, e.g., group B *Streptococci, E. coli*, and *Listeria monocytogenes* and perinatal herpes (HSV) infectionIf the neonate has fever recorded at home by reliable parents, the patient should be treated as febrile neonateIf excessive clothing and blanket falsely elevate the temperature, the excessive covering should be removed and retake the temperature in 15--30 min**Management** All febrile neonates must be hospitalizedFull sepsis evaluation including blood, urine; CSF should be culturedCSF studies should include cell count, glucose, and protein level, Gram stain, cultures; HSV, and enterovirus PCR should be consideredBlood and urine cultures warrantedChest radiograph may be includedChild should receive empiric antibiotics such as cefotaxime or gentamicin + ampicillinAcyclovir shouldbe included if HSV infection is suspected

### Fever in 1--3-Month-Old Infants {#Sec144}

**Background** Large majority of children with fever without localizing signs in 1--3 months age group likely viral syndromeMost viral diseases have distinct seasonal pattern, unlike bacteria, e.g., respiratory syncytial virus, and influenza more common during winter and enterovirus infection more common during summer and fall**Management** Ill-appearing (toxic)febrile infants ≤ 3 months:Require prompt hospitalization, immediate parenteral antibiotics after blood and CSF cultures are obtainedWell-appearing infants 1--3 months previously healthy with no evidence of focus of infection:WBCs count of 5000--15,000 cells/μL, an absolute band count of ≤ 1500 cells/μL, normal urinalysis, and negative culture (blood and urine) results are unlikely to have a serious bacterial infectionThe decision to obtain CSF studies in the well-appearing 1--3 months old infant depends on the decision to administer empiric antibioticsIf close observationwithout antibiotics planned, a lumbar puncture may be deferred

### Fever in 3--36 Months of Age {#Sec145}

**Background** Approximately 30% of febrile children in the 3--36 months age group have no localizing signs of infectionViral infections cause most fevers in this populationRisk factors indicating probability of occult bacteremia: Temperature ≥ 39 °C, WBC count ≥ 15,000/μL, elevated absolute neutrophil count, bands, ESR and C-reactive protein (CRP)The risk of bacteremia and/or pneumonia or pyelonephritis among infants 3--36 months of age increases as temperature (especially \> 40 °C) and WBC count (especially \> 25,000) increase**Management** Toxic-appearing febrile children 3--36 months of age who do not have focal infection should be hospitalized, with prompt institution of parenteral antibiotics after blood, urine, and CSF cultures are obtained (full sepsis evaluation)For nontoxic-appearing infants who have temperature \< 39 °C: Can be observed as outpatient with no diagnostic test or antibioticsFor nontoxic infants who have rectal temperature ≥ 39 °C, options include obtaining a blood culture and administering empiric antibiotic therapy (ceftriaxone, a single dose 50 mg/kg not to exceed 1 g); or blood culture with no antibiotic and observing the patient within 24 h as outpatient. (Careful observation without empiric antibiotics is generally prudent)

### Fever of Unknown Origin (FUO) {#Sec146}

**Background** FUO was defined as:More than 8 days' duration of illness. Temperature greater than 38.3 °C (101 °F) on several occasionsFailure to reach adiagnosis despite 1 week of investigationPatients with undiagnosed FUO (5--15% of cases) generally have a benign long-term course, especially when the fever is not accompanied by substantial weight loss or other signs of a serious underlying diseaseFUO lasting \> 6 months is uncommon in children and suggests granulomatous or autoimmune disease (Table [9.4](#Tab4){ref-type="table"})**Approach** Age of the patient is helpful:Children \> 6 years of age often have respiratory or genitourinary tract infection, localized infection (abscess, osteomyelitis), JIA, or (rarely) leukemiaAdolescent patients more likely to have TB, inflammatory bowel disease, autoimmune process, or lymphoma in addition to the causes of FUO in younger childrenExposure to wild or domestic animals, and zoonotic infectionHistory of pica should be elicited; ingestion of dirt is particularly important due to infection with *T. canis* or *T. gondii*Physical examination isessential to find any physical clues to underlying diagnosis, e.g., lymphadenopathy, rash, joint swelling, etc.Laboratory determinedon case-by-case basisESR \> 30 mm/h indicates inflammation and needs further evaluationESR \> 100 mm/h suggests tuberculosis, Kawasaki disease, malignancy or autoimmune diseaseLow ESR does not eliminate the possibility of infectionCRP is another acute phase reactant that is elevated and returns to normal more rapidly than ESRCultures, serologic studies, imaging studies, and biopsies, depending on the individual case**Treatment** The ultimate treatment of FUO is tailored to the underlying diagnosisEmpiric trials of antimicrobial agents may be dangerous and obscure the diagnosis of infective endocarditis, meningitis, parameningeal infection, and osteomyelitisAntipyretics for fever and relief of symptoms Table 9.4Differential diagnosis of fever ofunknown originFever typeDifferential diagnosisInfectiousViral: EBV, CMV, hepatitis, HIV, parvovirus B19Bacterial: tuberculosis, cat scratch, *Brucella*, *Salmonella*, meningococcemiaCommon: otitis media, sinusitis, pneumonia, UTI, osteomyelitis, septic arthritis, meningitisLess common: malaria, Lyme disease, endocarditisRheumatologicJuvenile idiopathic arthritis, SLE, dermatomyositisOncologicLeukemia, lymphoma, neuroblastoma, Ewing sarcoma, hemophagocytic lymphohistiocytosisAutoimmuneInflammatory bowel disease, macrophage activation syndromeDrug relatedPenicillin, cephalosporins, sulfonamides, acetaminophenOtherKawasaki disease, thyrotoxicosis, factitious fever*EBV* Epstein-Barr virus, *CMV* cytomegalovirus, *UTI* urinary tract infection, *SLE* Systemic lupus erythematosus

Central Nervous System (CNS) Infections {#Sec147}
=======================================

Encephalitis {#Sec148}
------------

**Definition** Inflammation of the brain**Causes** Viral, e.g., West Nile virus and herpesvirus (most common)Bacteria, e.g., mycoplasma, tertiary syphilisNoninfectious, e.g., autoimmunePrion proteinParasiticFungalAcute cerebellarataxiaAtaxiaNystagmusCerebellar dysarthria**Epidemiology** WNV remains the most commonly encountered arboviral encephalitis agentCalifornia encephalitis viruses cause the greatest proportion of symptomatic pediatric infectionsEastern equineencephalitis has the highest overall mortality rateThe importance of local epidemiological information and seasonality cannot be ignoredEnteroviruses are most often seen in spring and summer; arthropod-borne illnesses in the summer and fall**Clinical presentation** Altered mental statusSeizuresWeaknessSensory disturbancesNonepileptic movement disordersYoung children in absence of identifiable cause may present with:SomnolenceDisinterest in feedingWeak suck and irritabilityLoss of head controlAbnormal eye movementsFurther clinical clues:Fever (either acutely or in the 1--4 weeks interval before the onset of symptoms)Meningeal irritationAny child presentingwith uncharacteristic behavior that is persistent and disproportionate to environmental and situational factors**Initial evaluation of the patient includes** Seasonal presentationHistory of immunosuppressionTravel historyRecent localepidemiological informationPresence of focal neurologic symptoms or deficits.**Investigation** CBCComplete metabolic panelUrinalysisMRI or CTscan for intracranial pressure (ICP)Electroencephalogram (EEG)Enteroviral infections can produce a sepsis-like syndrome with more remarkable hematologic abnormalitiesNeonatal HSV infections sometimes produce hepatic function abnormalities and disseminated intravascular coagulationSyndrome of inappropriate antidiuretic hormone secretion (SIADH)Lumbar puncture if normal pressureCerebrospinal spinal fluid study:The lumbar puncture is the single most utilized test for the diagnosis of encephalitisIncreased opening pressureNormal or elevated protein concentrationNormal glucose levelPleocytosis, polymorphonuclear leukocytes; then converts to lymphocytic in many viral casesMonocytic; predominance may show with progression of the diseaseHemorrhagic pleocytosis with HSVAtypical lymphocytes with EBVMononuclear leukocyteswith echovirus or varicella-zoster infectionPCR amplification of viral DNAPleocytosis tends to beless dramatic in parainfectious encephalitis or acute cerebellar ataxiaFourfold rise in titer, especially IgM, against a suspected agent is most often considered diagnosticIV acyclovir while waiting for lumbar puncture, or while waiting for laboratory results, including HSV PCRIntracranial hypertensionconservative measuresHead elevationHyperventilationFluid restrictionMannitol is used on a limited basis**Treatment of seizure** Benzodiazepines (midazolam, lorazepam, diazepam) in the beginning followedby loading dose of fosphenytoin, or phenobarbital II

Meningitis {#Sec149}
----------

### ***Neonatal Streptococcal Meningitis*** {#Sec150}

Guillain--Barré syndrome remains the predominant neonatal meningitis pathogenEarly-onset disease: Infants typically manifest with signs suggestive of sepsis, oftenwith pneumonia, but less commonly with meningitisLate-onset disease:Infants typically are 3--4 weeks of age and present with meningitis or bacteremia***Neonatal Gram-negative meningitis*** Gram-negative bacillary meningitis is rare, *E. coli* being the most commonly isolated pathogenOther Gram-negativeneonatal meningitis pathogens such as *Citrobacter koseri, Enterobacter sakazakii,* and *Serratia marcescens****Neonatal herpes simplex (HSV) infection*** HSV in the newborn can present as isolated skin or mucous membrane lesions, encephalitis, or disseminated processHSV infection occursmost commonly in infants born to mothers who have active primary infectionFrequently no maternal history or clinical evidence is available to alert the practitioner to this diagnosisThe incubation period is 2 days to 2 weeks, and most infants who develop HSV CNS infection are 2--3 weeks of age***Neonatal meningitis due to Listeria*** Common sources:Unpasteurized milkSoft cheesePrepared ready-to-eat meatsUndercooked poultryUnwashed raw vegetablesCan precipitate abortion and preterm deliverySeptic appearance in the neonate is typical in cases of early onsetPapular truncal rash has been identified***S. pneumoniae*** Pneumococcus is the leading pathogen causing bacterial meningitisin infants and young children in developed countries***N. meningitidis*** Meningococcal disease generally occurs in otherwisehealthy individuals and often has a fulminant presentation with high fatality rates**Aseptic meningitis** Enterovirus is the most common etiology*B. burgdorferi* in mid-Atlantic states (Lyme)Vasculitis in the setting of systemic lupus erythematosus or Kawasaki disease.Drug-induced such as ibuprofen, and IV immunoglobulin**Other causes of meningitis** *M. tuberculosisB. burgdorferiR. rickettsii***Clinical manifestations** Infants younger than 1 month of age who have viral or bacterial meningitisFeverHypothermiaLethargyIrritabilityPoor feedingSigns and symptoms of increased ICP and meningeal inflammationVomitingApneaSeizures can also occurOlder children and adolescents often experienceMalaiseMyalgiaHeadachePhotophobiaNeck stiffnessAnorexiaNausea**Physical examination** Altered levels of consciousness can present as irritability, somnolence, lethargy, or comaICP include:PapilledemaDiplopiaUnilateral or bilateral dilated pupilsPoorly reactive pupilsBulging fontanelle in infantsHead circumference should always be obtained, especially in those who have an open fontanelleMeningismus is suggestive of meningeal irritationKernig sign:The patient lies supine and the thigh is flexed at a right angle to the trunk. If knee extension from this position elicits pain, the Kernig sign is positiveBrudzinski sign:The patient lies supine and flexes his or her neckA positive sign occurs if the patient also reflexively flexes the lower extremities, typically at the kneesAbsence of Kernig and Brudzinski signs does not exclude meningitisExanthems typical for enterovirus, borreliosis (erythema migrans), and invasive meningococcal or pneumococcal disease (petechiae and purpura) may be present**Diagnosis** All children who are suspected of having meningitis should have their CSF examined unless lumbar puncture is contraindicatedContraindications of lumbar puncture include:Focal neurologic deficitsSigns of increased ICPUncorrected coagulopathyCardiopulmonary compromiseCT scan is performed before lumbar puncture if any sign of ICP presentCSF findings in bacterial meningitis (Table [9.5](#Tab5){ref-type="table"})Glucose concentrationis usually less than one half of the measured serum valueProtein value often is greater than 100 mg/dLWBC often greater than 1000/mcL, with a predominance of polymorphonuclear leukocytesGram stain is extremely helpful if positiveCSF culture remains the gold standard for diagnosing bacterial meningitisCSF finding viral meningitisWBC count of 50--500/mcLNeutrophil predominance is common early in the course of infection, shifting to lymphocytic predominance quickly during the illnessGlucose and protein concentrations frequently are normal, although the protein value can be slightly elevated. Gram stain is universally negativeIn cases of enteroviral meningitis, enteroviral PCR can confirm the diagnosisTuberculous meningitis,epidemiologic clue, high protein, and lymphocytosisSIADH and hyponatremia commonly occur in bacterial meningitisLeukopenia, thrombocytopenia, and coagulopathy may be present in meningococcal and rickettsial infections**Management** Therapy shouldnot be delayed if CNS infection is suspectedAppropriate antimicrobials are required in bacterial meningitis, HSV encephalitis, Lyme meningitis, tuberculous meningitis, and rickettsial infection; in all cases, timely diagnosis and correct antimicrobial choice are criticalIf the practitioner cannot perform a lumbar puncture or there are contraindications to CSF examination, a blood culture should be obtained and antibiotics administered promptly**Drug choice and duration** For infantsAmpicillin (300 mg/kg/day divided every 6 h) and cefotaxime (300 mg/kg/day divided every 6 h) is appropriate. Gentamicin can be used instead of cefotaximeAcyclovir (60 mg/kg/day divided every 8 h) should be added if HSV infection is a concernVancomycin (60 mg/kg/day given every 6 h) should be added, if the Gram stain suggests pneumococcusChildren older than 1--2 months of ageVancomycin (60 mg/kg/day divided every 6 h) plus ceftriaxone (100 mg/kg/day given in one dose or divided into two doses) or cefotaxime (200--300 mg/kg/day divided every 6 h) should be used for empiric coverageOnce culture and susceptibilitydata are available, definitive therapy can be selectedHSV meningitisNeonatal HSV CNS infectiontypically is treated with IV acyclovir (60 mg/kg/day divided every 8 h) for 21 daysThe dosing for non-neonates is 30 mg/kg/day divided every 8 h IV for 14--21 daysFollow-up CSF HSV DNA PCR should be evaluated at day 21 and the course of therapy extended if the result is still positive**Corticosteroids in bacterial meningitis** Adjunctive treatment has reduced rates of mortality, severe hearing loss, and neurologic sequelae, significantly in adults who have community-acquired bacterial meningitisFor children beyond the neonatal age groups, available data suggest that the use of adjunctive corticosteroids may be beneficial for Hib meningitis and could be considered in cases of pneumococcal meningitisThe dose of dexamethasone for bacterial meningitis is 0.6 mg/kg/day divided into four doses and administered IV for 4 days. The first dose should be given before or concurrently with antibiotics**Care of the child exposed to meningitis** Meningococcal and Hib disease create an increased risk for secondary infection in contactsRifampin generally is the drug of choice for chemoprophylaxisin children**Prognosis for meningitis** Intellectual deficits (intelligence quotient \< 70), hydrocephalus, spasticity, blindness, and severe hearing loss are the most common sequelaeHearing loss occurs in approximately 30% of patients, can be unilateral or bilateral, and is more common in pneumococcal than meningococcal meningitis Table 9.5Cerebrospinal fluid analysisType of infectionWhite blood cellsProteinGlucoseBacterial meningitis\> 1000/μLHighLow (less than half of serum)Viral meningitis (viral)\< 500/μLNormalUsually normalTuberculosis\< 500/μL (predominant lymphocyte)Very highLow (less than half of serum)

Brain Abscess {#Sec151}
-------------

**Causes** Chronic otitis mediaParanasal sinus infectionOtogenic infections, poor dental hygiene/complications from dental proceduresMastoiditisMetastatic spread, e.g., endocarditisRight-to-left cardiac or pulmonary shunts, especially in the presence of cyanotic congenital heart diseaseNeurosurgical procedures (VP shunt)Penetrating skull injury, congenital head and neck lesionsImmunosuppressionCommonly identified microorganisms: *Streptococci* and *Staphylococci***Clinical presentation** Triad of fever, headache, and focal neurologic deficitHeadache (most common)May be throbbingWorsens with changes in posture or Valsalva maneuverVomitingDrowsinessConfusionComaHemiparesisPapilledema**Frontal lobe abscesses** Apathy , memory deficitsPersonality changeMental slowing**Cerebellar abscesses** NystagmusDefective conjugate eye movements to that sideAtaxiaHypotonia**Laboratory diagnosis** Little in the laboratory investigation of patients who have brain abscesses is specific to the diagnosis except for culture of the purulent material and antibiotic sensitivity of the responsible organism**Neuroimaging** CT scan of the brainIll-definedLow-density change within the parenchymaEnhancement occurs following administration of contrast materialClassic ring-enhancing lesion with surrounding edemaCalcification is common in abscesses in neonatesMRI**Antimicrobial therapy** For abscesses arising as a result of sinusitis in which *Streptococci* are the most likely organisms, penicillin or cefotaxime and metronidazoleChronic otitis media or mastoiditis often is associated with *P. aeruginosa* and *Enterobacteriaceae*, antibiotics to treat abscesses secondary to these infections should include penicillin, metronidazole, and a third-generation cephalosporinMetastatic abscesses require a regimen based on the likely site of primary infection*S. aureus* is commonly isolated in abscess following trauma**Surgical intervention** Provide a specimen of purulent material for bacteriologic analysis and antibiotic sensitivitytestingRemove purulent material, thereby lowering ICP and decreasing the mass effect of the abscessDecompress and irrigate the ventricular system and debride the abscess in the event of its rupture into the ventricular system**Prognosis** Brain abscess is a destructive lesionNeurologic sequelae:Epilepsy, motor deficits, visual field cuts, learning disability, hydrocephalus requiring VP shunt placement

Pearls and Pitfalls {#Sec152}
===================

Monospot testing for acute mononucleosis is not indicated for children \< 5 years of age because results are not reliable in young children.For children with multiple ulcerations of buccal mucosa and conjunctival involvement (mucous membranes) with skin rash, think erythema multiforme major (Stevens--Johnson syndrome).For children with ulcerations of posterior pharynx and painful papules on palms and soles, think enterovirus (especially Coxsackie virus) causing hand, foot, and mouth diseaseFor a child with pharyngitis and redness of skin creases of anterior cubital fossae (Pastia lines, also called Thompson sign), think Group A Strep (strep throat).Egg allergy, including anaphylaxis, is not a contraindication to influenza vaccination. Only persons with a previous severe allergic reaction to flu vaccine should not receive flu vaccine.For returning travelers with fever, obtain malaria testing immediately and begin appropriate therapy (artemether--lumefantrine or atovaquone--proguanil for *P. falciparum*) if positive. Do not delay!Children \< 2 years old can be colonized with *C. difficile* and may test positive for the organism. Only patients with *C. difficile* toxin production should be considered for treatment with first-line oral metronidazole.Patients with a classic bull's eye rash at the site of a tick bite do not require diagnostic testing. Treat for early localized Lyme disease with doxycycline(amoxicillin or cefuroxime for children \< 8 years old).A positive blood culture for *Candid*a should be acted upon, including repeat blood culture and IV antifungal therapy with central line removal (if associated). A positive sputum culture for *Candida* may represent colonization and should be taken in the clinical context.Rash that begins on wrists and ankles, spreading centrally to palms/soles, is likely Rocky Mountain spotted fever. Treat with doxycyclineno matter what age.Children who return from travel to the Middle East or Central America with ulcerative skin lesions and no systemic symptoms may have cutaneous Leishmaniasis.*Kingella kingae* is an etiologic agent of indolent septic arthritis or osteomyelitis in a young child. Can also cause bacteremia in infants and endocarditis in older children.Uncommon causes of fever in pediatrics include osteomyelitis, intraabdominal abscess, deep venous thrombosis, Still disease, recurrent fever syndromes (periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA), and familial Mediterranean fever).CNS complications of HIV include infection (cryptococcal meningitis, toxoplasmosis, CMV encephalitis, neurocysticercosis), lymphoma, progressive multifocal leukoencephalopathy (PML), peripheral neuropathy, and HIV encephalopathy.Nontuberculous mycobacteria can cause unilateral submandibular lymphadenitis with a violaceous hue in young children. Primary treatment is surgical excision, not antibiotics. Excision prevents fistula formation.Most mild community-acquired pneumonia can be treated as outpatient with oral amoxicillin as first-line therapy in patients who can tolerate oral fluids.The most common etiology for osteomyelitis *and* septic arthritis is *S. aureus*. Persons with sickle cell disease are at higher risk for *Salmonella.*For post-exposure rabies prophylaxis, administer rabies immune globulin at the bite site and rabies vaccine at a contralateral site on days 0, 3, 7, and 14 (four total doses of vaccine). For immunocompromised persons (HIV), a fifth dose of rabies vaccine is given on day 28.To avoid botulism in the 1st year of life, avoid giving infants prepared cereals that contain honey, as these may also be a potential source.For TB testing, can use an interferon gamma release assay (IGRA) for children \> 2 years of age. Use skin testing for younger children.
